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ABSTRACT
Pediatric patients are at an increased risk for medication errors and can benefit from processes
that facilitate and promote medication safety (Stone et al., 2010). Medication reconciliation (Med
Rec) is a valuable tool in improving patients’ medication safety and reducing adverse drug
events (The Joint Commission, 2015). The purpose of this evidence-based practice (EBP)
project was to improve the accuracy of the Med Rec process in a Midwestern pediatric
hematology/oncology outpatient clinic by developing, promoting, and evaluating a standardized,
collaborative Med Rec process. The Stetler EBP model guided the implementation of the
intervention, with the goal of integrating current evidence into current practice. Kotter’s Model of
Change laid the theoretical foundation for successful implementation of a current practice
change. This EBP project intervention included a patient and team member component. The
patient component consisted of a verbal call reminder to bring medications to the visit, a patient
handout emphasizing the importance of medication safety and reconciliation, and patient
education regarding Med Rec process. The team member component included education
regarding the importance of the Med Rec process and updates regarding Med Rec accuracy.
The outcomes measured included the number, type, and severity of medication discrepancies
and the number of voluntarily reported medication errors. Data were collected during Phase 1
(pre-intervention) and Phase 2 (post-intervention) by the physicians and the project leader (PL).
These data were analyzed using chi-square tests. The intervention lead to a significant increase
in the number of accurate Med Recs reported by the physicians between Phase 1 (n = 50, 70%)
and Phase 2 (n = 65, 90.8%) (X2 = 8.167, df = 1, p = .004). An insignificant decrease in the
number of accurate Med Recs was reported by the PL between Phase 1 (73.1%) and 2 (72.5%)
(X2 = .003, df = 1, p = 0.959). Physicians reported more incorrectness errors in Phase 1 (73.3%)
and Phase 2 (83.3%) than incompleteness errors (X2 = .481, df = 1, p = .786). PL reported more
incompleteness errors in Phase 1 (71.4%) and Phase 2 than incorrectness errors (81.8%) (X2 =
1.670, df = 2, p = .434). The majority of Med Rec inaccuracies were classified as minor during

ix

Phase 1 and 2 by the physicians (X2 = .827, df = 2, p = .363) and the PL (X2 = 1.039, df = 1, p =
.308). No inaccurate Med Rec was classified as severe by physicians or the PL. Finally, there
were no voluntary medication errors were reported during the duration of the EBP project.
Revision and replication of this EBP project would be helpful in further improving Med Rec
accuracy in this setting.
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CHAPTER 1
INTRODUCTION
In recent years, the importance of medication safety has been emphasized by
healthcare regulatory bodies. Medication safety has also been the focus of several
internationally lead initiatives (Agency of Healthcare Research and Quality (AHRQ), 2012;
Institute of Healthcare Improvement (IHI), 2016; The Joint Commission, 2015; World Health
Organization (WHO), 2015). In 2006, in an effort to improve medication safety, the Joint
Commission called for accurate and complete medication reconciliation (Med Rec) across the
continuum of care (Varkey, Cunningham, & Bispring, 2007).
The Joint Commission’s third National Patient Safety Goal (NPSG), in 2015, was to
improve the safety of using medications (The Joint Commission, 2015). This goal emphasized
an organization’s focus on the reduction of medication discrepancies and errors (The Joint
Commission, 2015). Specifically, NPSG.03.06.01 cites the role of Med Rec in improving
medication safety (The Joint Commission, 2015). According to the Joint Commission (2015),
Med Rec facilitates identifying and resolving medication discrepancies, such as duplications,
omissions, and interactions (The Joint Commission, 2015).
According to the IHI (2016), Med Rec can be defined as “a process of identifying the
most accurate list of all medications a patient is taking — including name, dosage, frequency,
and route — and using this list to provide correct medications for patients anywhere within the
health care system (Medication Reconciliation Review section, para. 2).” Med Rec plays a
pivotal role in identification and correction of medication discrepancies, leading to improved
medication safety (The Joint Commission, 2015). The ultimate goal of Med Rec is to create an
all-inclusive medication list that informs both the patient and the healthcare provider (The Joint
Commission, 2015). Med Rec is the responsibility of the patient and the entire healthcare team
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(Redmond et al., 2013). Developing and agreeing on an accurate medication list is a
collaborative effort.
The Med Rec process has three steps: verification, clarification, and reconciliation
(Redmond et al., 2013). Verification is the act of generating a list of the patient’s current
medications, using various sources of information (Redmond et al., 2013). The sources of
information can include: the patient, the general practitioner, the electronic health record (EHR),
or the pharmacy records (Redmond et al., 2013). Medications include prescription medications,
over-the-counter (OTC) medications, vaccines, vitamins, nutritional supplements, and
complementary medications (AHRQ, 2015; Barnsteiner, 2008). After the medication list is
verified, clarification occurs. Clarification occurs when the medications are checked for
appropriateness (Redmond et al., 2013). In this instance, appropriateness means intentional or
unintentional changes to the medication list that need to be made (Redmond et al., 2013). The
final step in the process is when the medication list is reviewed and any changes are
documented (Redmond et al., 2013). Changes can include medication additions, subtractions,
or modifications (Redmond et al., 2013). Failure to ensure an accurate medication list may
result in medication error, subsequent adverse drug events (ADEs), and ultimately comprised
patient safety (Redmond et al., 2013).
Med Rec should be performed at any and all transitions of care (AHRQ, 2012; IHI, 2016;
The Joint Commission, 2015). Transitional care can be defined as “changes in the level,
location, or providers of care as patients move within the healthcare system (Redmond et al.,
2013, p. 3).” Transitions of care can include: admission, discharge, and transfer (AHRQ, 2012).
Transitions of care are particularly vulnerable times, in which medication discrepancies and
errors occur more frequently (AHRQ, 2012). According to Redmond et al. (2013), more than
40% of medication errors take place at transitions of care as a result of inaccurate Med Rec. In
addition, it was found that there was a 30-70% variance in medications prior to and after
hospital admission, a transition of care (AHRQ, 2012).
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Med Rec is not without its challenges. Challenges include: accuracy of patient
information given to the healthcare provider, willingness of the patient to give information, time
efficiency, and effectiveness of the electronic or paper documenting system (The Joint
Commission, 2015). Coffey, Cornish, Koonthanam, Etchells, and Matlow (2009) cited barriers to
Med Rec that included: a multi-step process, the inter-professional nature of the Med Rec,
staffing resources, and frequent staff turnover. Despite these barriers healthcare providers are
urged to make a good faith effort to complete an accurate and complete Med Rec, at all
transitions of care (The Joint Commission, 2015).
The use of Med Rec has been shown to decrease medication errors and subsequent
ADEs (IHI, 2016; Redmond et al., 2013). Med Rec has been studied in many clinical practice
settings, such as inpatient hospitals and outpatient offices. For example, Varkey et al. (2007)
examined improving the Med Rec process, in an adult outpatient primary care setting. The
authors found that after a multifaceted intervention the average number of medication
discrepancies per patient decreased by more than 50%, from 5.24 to 2.46 discrepancies per
patient (Varkey et al., 2007).
In addition to various settings, Med Rec has been examined and shown to be
promisingly beneficial in different age groups (Coffey et al., 2009; Gardner & Graner, 2009;
Huynh et al., 2016; Nassaralla, Naessens, Chaudhry, Hansen, & Scheitel, 2007; Stone,
Boehme, Mundorff, Maloney, & Srivastava, 2010; Terry, Solanki, Sinclair, Marriott, & Wilson,
2010; Varkey et al., 2007, Weingart et al., 2007). One study focused on Med Rec process
implementation at one adult hospital and one pediatric hospital (Coffey et al., 2009).
Unfortunately, the authors did not provide the pediatric specific data, regarding the reduction in
medication discrepancies. However, at the adult hospital, implementation of a Med Rec process
decreased the total number of discrepancies identified from 224 to 120 (Coffey et al., 2009).
As discussed previously, both adult and pediatric studies have examined the effect of
implementing a Med Rec process. Med Rec can be an extremely important tool in pediatric
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patient care. Pediatric medication safety is oftentimes complex for many reasons, including:
weight based calculations, various medication formulations, and developmental levels making it
difficult for children to communicate adverse reactions (Stone et al., 2010). Healthcare providers
must have an accurate weight, convert the weight to kilograms, and then chose the appropriate
medication formulation and concentration (McPhillips et al., 2005). These steps make children
particularly vulnerable to medication errors. After the medication is prescribed, the caregivers of
the child must be educated to ensure proper medication administration at home.
When Kaushal et al. (2007) examined the rates and types of ADEs in six pediatric
outpatient offices, they found that the rate of preventable ADEs was 3% in two months (95% CI
[3, 4]) and that 14% of the preventable ADEs were serious. Kaushal et al. (2007) also found that
47% of the preventable ADEs were related to parent drug administration. The authors
recommended improved communication regarding medications between healthcare providers
and parents to reduce ADEs (Kaushal et al., 2007). Furthermore, Walsh et al. (2009) examined
medication errors among adults and children with cancer in an outpatient setting. Almost 19% of
pediatric visits involving medications were associated with a medication error (95% CI [12.5,
26.9]) (Walsh et al., 2009). This rate was higher than the adult comparison group with only 7.1%
of visits associated with a medication error (Walsh et al., 2009).
Cancer care has recently shifted from mostly inpatient care to the majority of care
occurring in the outpatient setting. This shift relocates the complex care oncology patients
receive to outpatient settings. According to Walsh et al. (2009), “systems to prevent outpatient
medication errors are often inadequate because of factors such as lack of recognition of errors,
communication problems, and fragmentations of care (p. 891).” Oncology patients receive
complex chemotherapy regimens in an outpatient setting. In addition, oftentimes part of their
chemotherapy regimen is oral chemotherapy administered at home (Walsh et al., 2009). The
complexity of oncology care, coupled with the complexity of pediatric medication administration
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places pediatric oncology patients at a significant risk for medication discrepancies and
subsequent ADEs (Walsh et al., 2009).
The purpose of this evidence-based practice (EBP) project was to improve the accuracy
of the Med Rec process in a pediatric hematology/oncology outpatient clinic by developing,
promoting, and evaluating a standardized, collaborative Med Rec process.
Background
As previously mentioned, the Joint Commission’s third 2015 NPSG focused on
medication safety. Accredited organizations are required to complete Med Rec at transitions of
care (The Joint Commission, 2015). In addition to the Joint Commission, the IHI also
emphasized the importance of medication safety, more specifically the role of Med Rec in
medication safety (IHI, 2016). In 2005, the IHI launched its 100,000 Lives Campaign with the
goal of reducing morbidity and mortality in the United States (IHI, 2005). One of the pillars of the
100,000 Lives Campaign was implementing Med Rec, specifically with the goal of preventing
ADEs (IHI, 2005).
In addition to the Joint Commission and the IHI, the World Health Organization (WHO)
formulated the High 5s Project in 2006. The goal of the High 5s Project was to improve patient
safety by implementing standardized operating protocols (SOPs) (WHO, 2013). One of the High
5s SOPs focused on Med Rec at transitions of care (WHO, 2013). The WHO (2015) stated that
“each SOP summarizes the problem, the strength of evidence that supports the solution,
potential barriers to adoption, potential unintended consequences created by the solution,
patient and family roles in the solution, and references and resources (Standard Operating
Protocols section, para. 2).”
Finally, the AHRQ and the National Institute for Health and Care Excellence (NICE)
developed and updated a guideline in 2015 entitled “Medicines Optimization: The Safe and
Effective Use of Medicines to Enable the Best Possible Outcomes (AHRQ, 2015).” The goal of
this guideline was to explain the best practice of care for patients who require medications. The
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guideline specifically discussed Med Rec at transitions of care. Particularly of relevance to this
project, the guideline recommends Med Rec in primary care settings be completed when a
patient is discharged from the hospital or another care setting and before any new prescription
or medication changes are made (AHRQ, 2015). The AHRQ is also responsible for the
development of a toolkit entitled “Medications at Transitions and Clinical Handoffs (MATCH)
Toolkit for Medication Reconciliation (AHRQ, 2012).” The toolkit urges healthcare providers to
review and re-design the Med Rec process currently in place at their clinical sites, in order to
improve patient safety (AHRQ, 2012). The toolkit has seven chapters that detail the process of
re-designing an existing Med Rec process (AHRQ, 2012).
Despite the AHRQ, the IHI, the Joint Commission, and the WHO recommending the use
of Med Rec, there is currently no specific recommendations from these organizations for Med
Rec in the pediatric outpatient setting. Team members at such facilities can certainly use these
organizations recommendations to develop a standardized, collaborative Med Rec process that
ensures accurate Med Rec and medication safety. Research examining Med Rec in outpatient
or ambulatory care settings is invaluable, as well as research examining Med Rec in pediatrics.
Statement of the Problem
This EBP project addressed the medication discrepancies found in completed Med
Recs, specifically the Med Recs in a pediatric hematology/oncology outpatient clinic. The impact
of a standardized, collaborative Med Rec process was examined. The pediatric and oncological
aspects of the population made the population extremely vulnerable to medication errors and
subsequent ADEs.
Data from the Literature Supporting Need for the Project
Extensive research has been conducted verifying the role of Med Rec in the reduction of
medication errors; however, little literature exists examining the impact of Med Rec in the
pediatric outpatient population. In a study using Med Rec in one pediatric and two adult
outpatient oncology clinics, 90% of incorrect medications lists were updated when a Med Rec
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process was used (Weingart et al., 2007). This result was in contrast to the standard care
group, where only 2% of medication lists were corrected (p < .001) (Weingart et al., 2007).
Standard care involved no formal reconciliation process. In the standard care group, 0.1
medication changes per patient were made, compared to 4.3 medication changes made in the
Med Rec group (p < .001) (Weingart et al., 2007). The rate of medication changes indicated the
medication list was being updated and revised. The Med Rec process included input from the
patient, nurse, healthcare provider, and the pharmacist, emphasizing the importance of a
collaborative effort to improve medication safety (Weingart et al., 2007).
A review of literature by Huynh et al. (2013) concluded that there was a lack of strong,
consistent evidence showing improvement of pediatric patient safety using Med Rec. However,
it was obvious that medication discrepancies were a major problem at transitions of care. Four
of the ten studies reviewed reported 22 to 73.6% of patients had an unintended medication
discrepancy or medication error. One study, included in the review, reported a rate of 1.5
discrepancies per patient. All ten of the studies included some form of a Med Rec intervention
(Huynh et al., 2013). The results of this review may indicate that Med Rec at pediatric transitions
of care is not as effective as what has been shown in adults. Further research is needed.
Most studies examining Med Rec in the pediatric population have been conducted in the
inpatient setting. A study, conducted in a tertiary care children’s hospital, examined the effect of
an EHR tool that displayed a patient’s pre-admission medication list beside the admission
medication orders (Hron et al., 2015). The use of this EHR tool lead to a statistically significant
decrease (53%) in rate of Med Rec errors (MREs) post intervention (p = .02; 95% CI [26, 87]).
Also, the risk of reported ADEs related to admission Med Rec was significantly lower postintervention (R2 = .24; p < .001; 95% CI [0.11, 0.53]) (Hron et al., 2015).
Huynh et al. (2016) conducted a study in which a clinical pharmacist provided several
points of care (a) interviewed the caregiver, (b) called the primary care provider (PCP) to obtain
the medication record, (c) recorded the patients medications brought from home, and (d)
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examined the initial admission medication orders. This intervention lead to the identification of
582 medication discrepancies in 1004 prescriptions (58%). Of those 582 medication
discrepancies, 209 were unintentional, 277 were intentional, and 96 were determined to be
trivial or related to nutrition. The authors concluded that Med Rec decreased the risk of harm
from unintended medication discrepancies. Also, with specific relevance to pediatric patients,
parents or caregivers were identified as the most sensitive or accurate source of information
(Huynh et al., 2016).
With little evidence in the literature focused on pediatric outpatient Med Rec, adult
outpatient studies shed light on the improvement of the outpatient Med Rec process. In an adult
internal medicine outpatient clinic, individual medication completeness improved from 9.7% to
70.7% (p < .001) after implementing an intervention that standardized the entire patient visit
process (Nassaralla et al., 2007). The entire medication list completeness improved from 7.7%
to 18.5%. The standardized visit process included (a) the patients being reminded to bring an
updated list of medications or the medication containers to their appointment; (b) the patients
recording the medications on a form when they arrived to their appointment; (c) a licensed
practical nurse (LPN) recording the medications in the EHR; (d) the physician continuing,
adding, deleting, or modifying the medications in the EHR; and (e) the transcriptionist checking
for differences between the physicians dictation and the patients documented medication list in
the EHR (Nassaralla et al., 2007).
In a similar study conducted at four adult ambulatory, primary care, internal medicine
clinics, the effect of a three phase intervention on Med Rec accuracy was assessed. The three
phases included (a) baseline data collection, (b) a LPN intervention, and (c) a patient
awareness intervention. After the interventions, a statistically significant increase in the number
of complete medications (76.5% to 88.3%) and complete medication lists (20.4% to 50.4%)
occurred (p < .03). Also, accuracy significantly improved from the pre-intervention phase to the
patient intervention phase from 11.5% to 29% (p = .014) (Nassaralla et al., 2009).

MEDICATION RECONCILIATION

9

In the literature, there currently is very little data focused on the pediatric outpatient
population and the Med Rec process. There are data from pediatric inpatient population studies
that support the use of accurate Med Rec’s. These data from the pediatric inpatient studies
emphasize the uniqueness of the pediatric population and emphasize the importance of
improving medication safety. As previously discussed, pediatric patients are at an increased risk
for medication errors given the steps involved in prescribing and administering medications
(McPhillips et al., 2005; Stone et al., 2010). When examining the applicability of the pediatric
inpatient Med Rec studies to the pediatric outpatient setting problems arise. The pediatric
inpatient setting Med Rec process, interventions, and outcomes differ from the Med Rec
process in the pediatric outpatient setting. For example, the outcome of many pediatric inpatient
Med Rec studies is often based on a comparison between the patient’s home medication list
and the admission medication orders. In the outpatient setting, there are no admission
medication orders that can be compared to the patient’s home medication list to determine Med
Rec accuracy. On the contrary in the outpatient setting, there is one list of the patient’s home
medications that is reviewed and updated. Although the adult outpatient studies focus on a
different population, the setting in which they take place has similar processes, interventions,
and measureable outcomes when compared to a pediatric outpatient setting. Given the lack of
existing pediatric outpatient data, the adult outpatient studies can serve as a framework for
improving the Med Rec process in a pediatric outpatient setting. It is imperative that the unique
aspects and needs of the pediatric population not be disregarded when examining the adult
outpatient studies for ways in which to improve patient medication safety.
Data from the Clinical Agency Supporting Need for the Project
In a pediatric hematology/oncology outpatient clinic, the project leader (PL) observed a
large number of medication discrepancies occurring at all three stages of the Med Rec process:
verification, clarification, and reconciliation. The clinic director and pediatric
hematology/oncology physicians were approached and also cited frustrations with the accuracy

MEDICATION RECONCILIATION

10

and effectiveness of the Med Rec process. As stated by one physician, “there is room for
improvement in our medication reconciliation process.” The director also evidenced a need for
improvement in an email communication stating “I know we continue to struggle with that
[medication reconciliation].”
Prior to this project, the Med Rec process at the agency had no accuracy assessment in
place. When asked about the frequency of medication discrepancies one physician stated “I find
errors every day.” The topic of Med Rec was discussed in depth with the clinic director and
various team members. All were receptive to making an EBP change in an attempt to improve
the Med Rec process and ultimately medication safety.
Purpose of the Evidence-Based Practice Project
Compelling Clinical Question
The purpose of this EBP project was to reduce the number of medication discrepancies
using a standardized, collaborative Med Rec process. The clinical question this EBP project
addressed was: Will a standardized, collaborative Med Rec process that is communicated to all
team members and patients, decrease the number of medication discrepancies?
PICOT Question
A PICOT question was developed and was related to the clinical question. The question
included the patient population (P), intervention of interest (I), comparison of interest (C)
outcome of interest (O), and the time (T). The PICOT question was as follows: In the pediatric
hematology/oncology outpatient population, how will the implementation of a standardized,
collaborative Med Rec process affect the number of medication discrepancies over the course
of two months, when compared to the current Med Rec practice?
Significance of the EBP Project
The goal of this EBP project was to reduce the number of medication discrepancies and
improve the current Med Rec process. The measureable outcome was the number of
medication discrepancies found prior to and after the intervention implementation. The severity
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and type of medication discrepancies were also recorded, in an effort to predict the potential
outcome of the discrepancy. The project site had a Med Rec process in place prior to this EBP
project, which fulfills the Joint Commission’s NPSG.03.06.01, that a Med Rec process must be
in place to be accredited (The Joint Commission, 2015). However, according to the PL’s
observation and various sources in the pediatric hematology/oncology outpatient clinic the Med
Rec process was not accurate. Ultimately, the accuracy of the Med Rec affects the patient’s
medication understanding and home medication administration.
The final goal of this EBP project was to decrease the number of ADEs reported in the
project sites computer system, related to medication errors. At the time of the EBP project, team
members were reminded to report ADEs in the electronic incident reporting system. With the
implementation of a standardized Med Rec process, it was hoped and predicted that there
would be a consistent or decrease in the number of ADEs reported in the incident reporting
system.
It was of utmost importance to keep the patient at the center of the care provided and
ultimately improve their medication safety. It was important to enlist and motivate all the team
members at the project site to ensure a collaborative effort. The ultimate goal was to produce
significant results that would lead to a permanent policy change, within the pediatric
hematology/oncology outpatient clinic.
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CHAPTER 2
THEORETICAL FRAMEWORK, EBP MODEL, AND REVIEW OF LITERATURE
The goal of this EBP project was to use current evidence found in the literature to
change and improve a clinical problem. It is important to discuss the theoretical framework that
guided the EBP change in the clinical setting and the EBP model used to guide the
implementation of this project. The theoretical framework that was used to guide this EBP
project was Kotter’s Model of Change. In addition to Kotter’s Model of Change, the Stetler EBP
Model was used to guide the implementation of best practice in the clinical setting.
Theoretical Framework
Overview of Theoretical Framework
The theoretical framework for this EBP project was Kotter’s Model of Change. Kotter’s
Model of Change laid a foundation to successfully implement an EBP project and change
current practice. Kotter used Lewin’s Stages of Change as a building block in developing his
change model (Ritter, 2011). The eight stages of Kotter’s change model are: (1) establish a
sense of urgency, (2) create a powerful guiding coalition, (3) develop a vision, (4) communicate
the vision, (5) empower others to act on the vision, (6) plan for and create short-term wins, (7)
consolidate improvements and produce more change, and (8) institutionalize new approaches
(Ritter, 2011). Kotter’s first four steps look at changing the current practice or status quo, similar
to Lewin’s unfreezing stage. Steps five through seven introduce the change, similar to Lewin’s
change stage. Finally, step eight seeks to make the changes standard practice, similar to
Lewin’s refreezing stage (Ritter, 2011).
The goal of the first stage of the Kotter Model of Change is to establish a sense of
urgency. The sense of urgency is focused on changing a current clinical problem. One strategy
to establishing urgency is to collect data on the problem that can be used as a tool to
communicate the scope of the problem (Young, 2015). Establishing a sense of urgency can
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reduce resistance to change and energize team members to be active participants in the
change (Fehr, 2016).
The second stage of Kotter’s Model is to create a powerful guiding coalition. The guiding
coalition is made up of key stakeholders that can help plan and implement the change (Fehr,
2016). It is important that this coalition have similar thoughts and ideas, regarding the future of
the change. A direct result of forming a coalition is collaboration and cooperation (Young, 2015).
After a coalition is formed, it is important to develop a vision, Kotter’s third stage. The
coalition works together to formulate a vision and strategy to implement the change (Young,
2015). The ultimate goal of this step is the development of a vision and strategy that is clearly
articulated (Fehr, 2016).
The fourth stage of Kotter’s Model is communicating the vision. According to Fehr
(2016), in this stage the vision must be communicated clearly, many times, and in different
forms. Ensuring clear communication can reduce confusion, misunderstandings, and ultimately
resistance to change (Young, 2015).
The fifth stage of Kotter’s Model is empowering others to act on the vision. The first four
steps alone do not cause change to occur. The fifth stage, however, is when the change begins
to be enacted. For this stage to be successful, all team members feeling and believing in the
proposed change is essential. The belief in the change will foster a sense of responsibility and
accountability for the success or failure of the new practice (Young, 2015). This step also
involves removing barriers to the change, including systems or structures that may impede the
change process (Ritter, 2011).
Once team members are empowered, the likelihood the change will be a success
increases. In order to facilitate continued investment in the change, the sixth stage focuses on
planning for and creating short-term wins. When a team member models or embraces the
change, a “short-term win” is created (Young, 2015, p. 456). During this stage, team members
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are recognized for embracing and accepting the change. This recognition can further team
member’s investment in the change (Young, 2015).
Once the change has begun to be accepted and celebrated, it is important to consolidate
improvements and produce more change, which is the seventh stage in Kotter’s Model. At this
time, reevaluation of goal and strategies occurs (Fehr, 2016). It is imperative to make certain
that the change is achieving the desired results. Each team member that accepts and adheres
to the change is important. The advancement to the eighth, and final stage, is quickened if more
team members buy into the new practice (Young, 2015).
The eighth, and final stage, of Kotter’s Model is institutionalizing new approaches. The
combined effort of all empowered team members can facilitate an anchoring of the change into
accepted and current practice (Young, 2015). As the change is seen as a success and benefits
are shown, the process will hopefully no longer be seen as new and difficult. The change will
become current best practice.
There are many aspects of change that were considered when implementing this EBP
project. Improving the Med Rec process, in the pediatric outpatient hematology/oncology
outpatient clinic, was not without its challenges. These challenges can be considered individual
or organizational level challenges. Individual barriers can include: fear of the unknown,
reduction in the need for personal fulfillment, real or perceived stress, loss of status or personal
power, and loss of equilibrium (Ritter, 2011, p. 375). Organizational barriers can include: lack of
a change agent, inadequate financial and/or capacity, poor leadership and resistance to change
by senior management, lack of the necessary technology, time restraints, or poor market
conditions (Ritter, 2011, p. 375). Kotter’s Model of Change facilitated the triumph over numerous
barriers, such as the ones listed above.
Application of Theoretical Framework to EBP Project
Stage 1-- Establish a sense of urgency. Prior to implementing the change, baseline
data were collected. These data were used as a tool to communicate and exhibit the clinical
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problem to team members. The PL collecting and presenting the data to the team members
produced a sense of urgency. Urgency regarding changing the current practice needed to be
formulated, in order to ensure decreased resistance and increased buy into the new practice.
Stage 2-- Create a powerful guiding coalition. By communicating and developing the
sense of urgency, a coalition was formed. The coalition was a multidisciplinary team of
individuals, who shared a common goal and vision. The multidisciplinary team included: unit
assistants, medical assistants (MAs), registered nurses, and physicians.
Stage 3-- Develop a vision. The coalition, at the project site, developed and strategized
ways to implement the evidence into practice. The goal and vision of the proposed change was
an improvement in the Med Rec process. It was the hope of the coalition that the change would
lead to improved patient safety. Through collaboration and cooperation, a vision of improved
patient care was realized.
Stage 4-- Communicate the vision. Communicating the vision clearly was of utmost
importance. Resistance may have occurred, if the vision was unclear or confusing to team
members. Communicating the vision of this EBP project occurred in different forms, such as
verbally, visually via PowerPoint®, and via email.
Stage 5-- Empower others to act on the vision. The goal of this EBP project was to
create a sustainable process that continued long after the implementation phase. With this goal
in mind, it was extremely important to empower the team members, at the project site to believe
in and act on the vision. This stage was undoubtedly the most challenging stage of the project
change. Barriers to change were recognized and an attempt was made to overcome them by
strategically examining the clinical problem. By presenting the baseline data and current
literature, team members felt a sense of investment in changing the current process. This sense
of investment lead to the team members working together to improve current practice.
Stage 6-- Plan for and create short-term wins. As discussed in Young (2015),
recognizing and rewarding change agents at the clinical site was helpful in facilitating continued
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support of the proposed change. Encouragement was provided both in person and via email.
Team members were kept up to date throughout the project. This was beneficial and
encouraged those resistant to change to actively participate in the change.
Stage 7-- Consolidate improvements and produce more change. As the project
proceeded and a few team members took an active role, the change began to not feel so new
and uncomfortable. On the contrary, the change briefly became part of the standard of care. To
facilitate team members taking an active role the PL was available to remind and encourage
team members. Also, the PL advocated for the team members and patients during the project.
Stage 8-- Institutionalize new approaches. As mentioned previously, one goal of this
EBP project was to develop a process that is beneficial, to both team members and patients,
and is sustainable. The sustainability continues to be derived from the empowered team
members, who invested in the change process.
Strengths and Limitations of Theoretical Framework for EBP Project
Kotter’s Change Model was useful when implementing an organizational change.
Kotter’s Model was easy to follow and simplistic, yet it was also thorough, when it came to the
entirety of the change process. The additional detail and steps that Kotter’s Model offered, in
comparison to Lewin’s Model of Change, was helpful to the novice PL. Also, the thoroughness
was appreciated in a climate, such as the project site, where change was resisted and difficult to
implement.
Kotter’s Change Model contains eight stages, which could be viewed as laborious and
overwhelming to those implementing a process change. The model was described in a linear,
step-by-step approach, and this was possibly more simplistic than making changes in a real
environment. Changing a policy, practice, or process was complex and was affected by many
circumstances. Finally, Kotter’s Model of Change could be considered a top-down approach. A
top-down approach, in some environments, may not be the most effective at changing a
process (Young, 2015).
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Evidence-based Practice Model
Overview of EBP Model
The Stetler Model of Evidence Based Practice was used to guide the implementation of
this EBP project. The Stetler Model was first published in 1976 and has been revised three
times since then (Dang et al., 2015). The model gives step-by-step, detailed directions for
incorporating research into practice. The practitioner-oriented model encourages the
assessment and use of research in the clinical practice setting, with the goal of providing safe
and effective care (Dang et al., 2015 & Young, 2015).
The Stetler Model has five phases: (1) preparation, (2) validation, (3) comparative
evaluation/decision making, (4) translation/application, and (5) evaluation (Dang et al., 2015 &
Young, 2015). In the first phase, preparation, a problem is identified; the context of the problem
is reviewed; and searching for evidence occurs. In the validation phase, the body of evidence is
systematically searched. The second stage also includes choosing and summarizing the
evidence. If sufficient evidence is found, in the validation phase, the EBP project progresses to
the third phase, comparative evaluation/decision making. The third phase involves organizing
and condensing the evidence. At the end of this phase, the data can be classified into three
categories: (a) do not use, (b) use, or (c) consider for later use. The fourth phase involves the
actual change in practice, or translation/application. The evidence is converted into the
recommended intervention of change. The application is planned and the implementation
strategy is put into action. Evaluation is the fifth, and final stage, of the Stetler Model. The
evaluation stage involves evaluating the plan and determining if the goals were met (Dang et al.,
2015 & Young, 2015).
Application of EBP Model to EBP Project
Phase 1-- preparation. According to many nationally recognized organizations, such as
the Joint Commission and the WHO, Med Rec can reduce ADEs (WHO, 2013; The Joint
Commission, 2015). It is recommended that Med Rec be done thoroughly and accurately to
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ensure the best possible medication history (BPMH) be formulated. This BPMH should be
formulated collaboratively, with the patient and the healthcare providers, at each encounter.
During this phase of the Stetler Model, the current state of the Med Rec process was assessed,
at the project site. It was found that multiple team members had concerns about (a) the
accuracy of the medication information provided by the caregiver, (b) the medication history
entered by the nurse, and (c) the reconciliation process as a whole. The accuracy of the Med
Rec process was the identified problem. The context of the problem was reviewed to further
determine the specific areas of the process that need improvement. A multiple database search
found literature dedicated to the Med Rec process.
Phase 2-- validation. After multiple databases were searched and literature was found,
the literature underwent systematic critiquing to evaluate the literatures strength and relevance.
Evidence was rated using the Melnyk and Fineout-Overholt (2015) levels of evidence rating
system. If the evidence was found to be relevant and applicable to the EBP project, it was
further critiqued using the Johns Hopkins Research or Non-Research Appraisal Tool (Dearholt
& Dang, 2012).
Phase 3--decision making. After the research was narrowed and critiqued to include
literature relevant to the EBP project, the literature was organized. Common themes were found
and the evidence was placed into one of three categories. The Stetler Model recommended
categories were (a) do not use, (b) use, or (c) consider for later use. The current Med Rec
process was reviewed and a PICOT question was developed.
Phase 4-- application. The application phase began after the project intervention was
developed, based on the relevant evidence. Also, institutional review board (IRB) approval from
both Valparaiso University and the project site was obtained, to properly protect the projects
participants. The project advisor guided this process, as well as the site contact liaison. Once
IRB approval was granted, the EBP project implementation was completed. The barriers to
implementation were assessed both prior to, during, and after implementation.
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Phase 5-- evaluation. The evaluation stage involved examining the implementation and
determining if the goals of the EBP project were met. The outcomes measured during the
application phase were the number, type, and severity of the medication discrepancies and the
total number of medication errors voluntarily reported. The first two outcomes would have ideally
been collected using the EHR, however this was not possible. After detailed discussions with
the information technology (IT) department is was determined that collecting the data from the
EHR was not possible. In this case, the EHR did not provide the PL the ability to see who made
Med Rec changes, what changes were made, and when the changes were made. Therefore,
the data were collected by the physicians, at the project site, who conduct the last step in the
Med Rec process and the PL. The physician’s evaluation served as an assessment of the
information the MA or nurse entered into the EHR. The PL evaluation served as an assessment
of the final Med Rec process product, ideally an accurate patient medication list. The third and
final outcome was collected using the computer system, where medication errors are voluntarily
reported. The number of reported medication errors during baseline data collection was
compared to the number of reported medication errors post-intervention.
The goal of the EBP project intervention was to decrease the number of the medication
discrepancies, decrease the severity of discrepancies, and decrease the number of medication
errors. The Stetler Model guided the implementation of the intervention, with the goal of
integrating the current evidence into current practice. The sustainability of the change in practice
depended on the success of the EBP project intervention and outcome evaluation.
Strengths and Limitations of EBP Model for EBP Project
Strengths of the Stetler Model include a step-by-step approach to implementing
evidence into practice. The step-by-step approach was extremely helpful to a novice EBP PL.
The Stetler Model can be easily applied to a variety of practice areas and clinical problems. The
visual flowchart and graph, that details the steps of EBP implementation, were helpful. The
steps laid the foundation for successful EBP implementation. The foundation and focus of the
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Stetler Model is critical thinking and using research findings to guide care, which was the
ultimate goal of this EBP project.
The Stetler Model’s limitations are few, but could include the number of steps and also
the complexity of each step. Although the visual representation of the model is helpful, the steps
could be seen as overwhelming and laborious. Finally, the model flows in a linear pattern, and
as discussed with the Kotter Model of Change, EBP implementation is complex. EBP change is
set up for success if a theoretical framework and EBP model are used to facilitate the change.
Literature Search
Sources Examined for Relevant Evidence
A thorough literature search was conducted to examine the evidence related to the
identified clinical problem. The following databases were searched: Cumulative Index for
Nursing and Allied Health (CINAHL), MEDLINE (via EBSCO), Nursing & Allied Health
Database, Cochrane Library, Joanna Briggs Institute EBP Database (JBI), and the National
Guideline Clearinghouse. The evidence was further narrowed using the limiters: English
language, publication years 2006-2016, and scholarly (peer-reviewed) journals. A variety of
search terms were trialed during the literature search and the final search terms included:
“medic* reconcil*” AND (outpatient* OR “ambulatory care” OR “primary care” OR pediatric* OR
infant* OR toddler* OR child* OR adolescen*). A list of the databases, search terms, search
results, and applicable articles can be found in Table 2.1.
The search term “medic* reconcil*” was used to include articles that used the term
“medication reconciliation” and also those that used the term “medicines reconcile.” The search
terms “outpatient* OR “ambulatory care” OR “primary care” were used to focus the search on
settings similar to the project site, an outpatient clinic. The goal of using these search terms was
to eliminate inpatient studies. The search terms “pediatric* OR infant* OR toddler* OR child* OR
adolescen*” allowed for the inclusion of studies with a population similar to the project site,
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Table 2.1
Literature Search Results
Database
CINAHL

MEDLINE
(EBSCO)

Nursing &
Allied Health
Database

Search Terms
“medic* reconcil*”
AND (outpatient* OR
“ambulatory care” OR “primary
care” OR pediatric* OR infant*
OR toddler* OR child* OR
adolescen*)
“medic* reconcil*”
AND (outpatient* OR
“ambulatory care” OR “primary
care” OR pediatric* OR infant*
OR toddler* OR child* OR
adolescen*)
“medic* reconcil*”
AND (outpatient* OR
“ambulatory care” OR “primary
care” OR pediatric* OR infant*
OR toddler* OR child* OR
adolescen*)

Article Found
154





Limiters
English language
Publication years
2006-2016
Scholarly (peerreviewed) journals

Results
139

Articles Used
6

344




English language
Publication years
2006-2016

326

2

16,096




English language
Publication years
2006-2016
Scholarly (peerreviewed) journals
Search terms in
abstract only
Publication years
2006-2016
Publication years
2006-2016
Not applicable

63

0

4

0

33

0

19

1




Cochrane

medication reconciliation

4



JBI

medication reconciliation

33



National
Guideline
Clearinghouse

medication reconciliation

19
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pediatrics. It is important to note that when the PL limited the search to studies involving Med
Rec, the outpatient setting, and the pediatric population there were insufficient results. An
example of the search that was found to be too narrow was “medic* reconcil*” AND (outpatient*
OR “ambulatory care” OR “primary care”) AND (pediatric* OR infant* OR child* OR toddler* OR
adolescen*). Therefore, the search was broadened to include articles that focused on the
applicable setting and/or the applicable population.
After the initial database searches were completed, the results were reviewed for
applicable articles. First, article titles were reviewed for applicability to the EBP project.
Secondly, abstracts were reviewed. If the article abstract was unavailable, the full text version
was found and reviewed for possible inclusion. Inclusion criteria included: Med Rec process
specific, outpatient and/or pediatric focused, and interventions that included both the patient and
the multidisciplinary healthcare team. Exclusion criteria included: adult inpatient focused and
Med Rec completion as the only outcome. Furthermore, if an article abstract was deemed
appropriate, the PL reviewed the full text of the article. Finally, the reference lists of applicable
articles were reviewed in an effort to identify additional sources.
Eight articles were found to be applicable to the EBP project and met the inclusion
criteria. Six articles were originally found in CINHAL and two in MEDLINE. No articles were
originally found in Nursing & Allied Health Database, JBI, Cochrane, or in article reference lists.
In addition to the eight articles, one clinical practice guideline (CPG) was found. The nine pieces
of evidence were assigned levels of evidence and critically appraised to ensure that the
literature review produced the best evidence regarding the topic, setting, and population.
Levels of Evidence
The Stetler Model of EBP, specifically the third phase, was applied and articles were
deemed usable, not usable, or possibly usable. Articles deemed usable were then thoroughly
reviewed and assigned a level of evidence based on the Melnyk and Fineout-Overholt (2015)
hierarchy of evidence. The Melnyk and Fineout-Overholt (2015) hierarchy of evidence consists
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of seven levels, from I to VII. Level I evidence is from systematic reviews (SRs) or metasynthesis of all relevant randomized controlled trials (RCTs). Level II evidence is obtained from
well-designed RCTs. To be deemed Level III evidence, the study must be a well-designed
controlled trial without randomization. Level IV is evidence from well-designed case-control and
cohort studies. Evidence is deemed to be Level V if it is from SRs of descriptive and qualitative
studies. Level VI is evidence from single descriptive or qualitative studies. Finally, Level VII is
evidence from the opinions of authorities and/or reports of expert committees. Level I is the
highest level of evidence and Level VII is the lowest level of evidence (Melnyk & FineoutOverholt, 2015).
The CPG in this review is based on SRs of RCT’s, single RCT’s, or observational
studies when no RCTs were available, and is therefore Level I evidence (AHRQ, 2015). Six
articles were found to be Level III, as they are quasi-experimental studies (Hron et al., 2015;
Nassaralla et al., 2007; Nassaralla et al., 2009; Stock, Scott, & Gurtel, 2009; Varkey et al., 2007;
Weingart et al., 2007). One article was deemed to be Level IV evidence, as it is a prospective
cohort study (Huynh et al., 2016). Finally, one piece of Level VII evidence was obtained and is a
review of literature (Huynh et al., 2013).
Appraisal of Relevant Evidence
The Johns Hopkins Research or Non-Research Appraisal Tool was used to determine
the quality of the research evidence (Dearholt & Dang, 2012). This research tool contains a
series of questions that guide the assessment of study quality. High quality is a consistent study
with generalizable results. The sample size must be sufficient for the study design and adequate
control must be demonstrated with definitive conclusions. Finally, a high quality study must have
consistent recommendations, based on a comprehensive literature review that includes a
thorough reference to scientific evidence. A study is considered good quality if there are: (a)
reasonably consistent results, (b) sufficient sample size for the study design, (c) some control,
(d) fairly definitive conclusions, (e) reasonably consistent recommendations, based on a fairly
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comprehensive literature review, that includes some reference to scientific evidence. Low
quality studies are studies with little evidence, inconsistent results, insufficient sample size for
the study design, or if conclusions cannot be drawn (Dearholt & Dang, 2012).
The Johns Hopkins Non-Research Appraisal Tool was used to determine the quality of
the non-research evidence, specifically the CPG and the review of literature (AHRQ, 2015;
Huynh et al., 2013). The tool contains a series of questions that guide the quality assessment;
either high, good, or low quality (Dearholt & Dang, 2012). For a CPG to be considered high
quality, it must be: (a) sponsored by a professional, public, private organization, or government
agency, (b) document a systematic literature search strategy, (c) have consistent results, and
(d) be developed or revised within the last five years (Dearholt & Dang, 2012). To be considered
good quality, the CPG must be: (a) sponsored by a professional, public, private organization, or
government agency, (b) document a reasonably thorough systematic literature search strategy,
(c) have reasonably consistent results, and (d) be developed or revised within the last five years
(Dearholt & Dang, 2012). Finally, to be considered low quality, the CPG must not: (a) be
sponsored by an official organization, (b) document a systematic literature search strategy, (c)
have consistent results, and (d) be developed or revised within the last five years (Dearholt &
Dang, 2012).
The guidelines for the quality of a review of literature differ, from the quality guidelines
for a CPG. To be considered high quality, a review of literature must have definitive conclusions
and scientific rationale (Dearholt & Dang, 2012). For a review of literature to be considered good
quality, fairly definitive conclusions must be drawn and logical argument for opinions must be
provided (Dearholt & Dang, 2012). Finally, low quality reviews do not provide conclusions
(Dearholt & Dang, 2012). All evidence was kept regardless of the level or quality rating, as to
represent the evidence that is currently available. Table 2.2 summarizes the evidence and
provides both the level and quality rating for each piece of evidence.
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Table 2.2
Methods Summary
Authors
Year Published
Hron et al.

Design
Sample
Quasiexperimental

2015
Quality
Improvement

Outcome

Intervention

Rate of nonintercepted
admission MREs,
identified by a
voluntary
reporting system

EHR tool that
displayed the preadmission
medication list
beside the
admission
medication orders

Time-series
Tertiary care
children’s hospitalall patients
admitted for one
year

Severity of MREs:
0-5 scale
0= intercepted
potential ADE’s
(before reaching
patient)
1= nonintercepted
potential ADE
(reached patient,
no condition
change)
2= minor ADE
3= moderate ADE
4= major ADE
5= catastrophic
ADE

Med Rec
compliance was
reported to
inpatient units

Results/Findings

Med Rec tool was used in <3% of
patients pre-intervention and in
83.8% of patients post-intervention
MRE’s:
Pre-intervention: 4.1 errors per
1,000 admissions
Post-intervention: 2.0 errors per
1,000 admissions
Statistically significant decrease
(53%) in rate of MRE’s post
intervention (p = .02; 95% CI [26,
87])
Risk of reported ADEs related to
admission Med Rec was
significantly lower post intervention
(R2 = .24; p < .001; 95% CI [0.11,
0.53])
Severity:
Intercepted potential ADEs (35% of
total errors)
Pre-intervention: 1.7 per 1,000
admissions
Post-intervention: 1.4 per 1,000
admissions

Level
Quality
Level: III
Quality:
High
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Non-intercepted potential ADEs
(42% of total errors)
Pre-intervention: 2.3 per 1,000
admissions
Post-intervention: 1.5 per 1,000
admissions
Minor ADEs (22% of total errors)
Pre-intervention: 1.7 per 1,000
admissions
Post-intervention: 0.4 per 1,000
admissions
Moderate ADEs (1% of total errors)
0.1 errors both pre and postintervention

Huynh et al.
2013

Review of
Literature, without
meta-analysis
Literature search
of PubMed, OVID
EMBASE, ISI Web
of Science, ISI
Biosis, CINHAL,
and OVID
International
Pharmaceutical
Abstracts
Inclusion criteria:
< 18 years of age
upon admission to

Medication
discrepancy at
pediatric
transitions of care
Clinical
significance of
discrepancy
Type of
discrepancy
Intervention used
specified

Pharmacy
computer system
that generates a
complete and
accurate Med Rec
form to serve as a
transfer order
BPMH form that
physicians were
expected to
complete, nurses
completed Med
Rec if <4
medications, if >4
medications
pharmacist

No major or catastrophic ADE’s pre
or post-intervention
No uniform outcome was used to
measure effect of Med Rec in the
pediatric population
There is little information or data on
using Med Rec in the pediatric
population
Using Med Rec in pediatrics, to
improve medication safety, is
challenging
Further research is needed to fully
understand the most beneficial Med
Rec process in pediatrics

Level:
VII
Quality:
High
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hospital, transfer,
or discharge, and
reported Med Rec
intervention

completed Med
Rec
Student
pharmacist
formulated BPMH

Exclusion criteria:
mixed pediatric
and adult data that
could not be
stratified, outside
pediatric age limit,
not original
research, did not
clearly define
discrepancies or
intervention

BPMH list
compiled using
five sources on
admission
Pharmacist
complied
independent
medication history
upon admission
and transfer

10 sources
6 prospective
observational
studies, 4
retrospective
observational
studies

Best possible
medication
discharge plan
was used at
patient’s discharge

7 full articles,
3 non-peer
reviewed,
conference
abstracts
Huynh et al.
2016

Prospective
Cohort

Introduction of
pharmacist in a
pediatric ER

Medication
discrepancies=
difference
between preadmission

4 stage Med Rec
by pharmacist
Clinical pharmacist
1. Interviewed
caregiver
2. Called PCP to
obtain

Overall, 1004 individual
prescriptions:
582 medication discrepancies/1004
prescriptions (58%), affecting 203
patients (83%)

Level: IV
Quality:
High
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4 pediatric
hospitals in the
United Kingdom
Inclusion criteria:
one long term
medication
prescribed
Exclusion criteria:
no long term
medications
prescribed, > 19
years of age,
caregiver not
present, drug list
not available, or
admitted outside
of routine hours

29
medication list
when compared
to initial
admission
medication orders
Intentional vs.
unintentional
discrepancies
Severity of
unintentional
discrepancies:
Class 1:
potentially minor
Class 2:
potentially
moderate
Class 3:
potentially severe

medication
record
3. Recorded
patients
medications
brought from
home
4. Examined
initial
admission
medication
orders
No previous Med
Rec process was
in place

209/582 unintentional
discrepancies, affecting 109/244
patients (45%)
277/582 (48%) intentional
discrepancies
96/582 (16%) discrepancies were
determined to be trivial or related to
nutrition
Severity:
Class 1: 22% of unintentional
medication discrepancies
Class 2: 50% of unintentional
medication discrepancies
Class 3: 28% of unintentional
medication discrepancies
Total time needed to complete the
Med Rec: 6-144 minutes (Mdn = 24,
IQR = 17-40)

n = 244
Time needed to
complete Med
Rec was
recorded

Nassaralla et al.
2007

Quasiexperimental
Before and after
Adult primary care,
internal medicine
clinic

Completeness of
Med Rec in EHR
(“complete”=
name, dose,
frequency, and
route
documented)

Parents/caregivers were the most
accurate source (81% correct)
compared to the pharmacist
completed regimen

Reviewed process
and shared data
with team
members
2 steps:
1. Educated all
team members

Medications were present at 38.5%
of admissions
Significant increase in
documentation of dose and route
Pre-intervention: 27.4% missing
dose, 85.8% missing route
Post-intervention: 21.7% missing
dose, 16.8% missing route (p < .03)
Sustainability: 12.9% missing dose,
13.1% missing route (p < .001)

Level: III
Quality:
Good
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Pre-intervention:
n = 65
Post-intervention:
n = 100
Sustainability
phase: n = 65
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Correctness of
Med Rec in EHR
(“correct”= no
discrepancies in
the name, dose
frequency, or
route, between
the med list in
EHR and the
medications the
patient was taking
at home)
Phone call to
collect
information from
patient
Accurate =
complete and
correct Med Rec

what constitutes a
complete and
correct medication
list, shared results
of pre-intervention
data with nurses
and physicians,
same Med Rec
review process for
all patients (LPN
obtained and
documented
medication history
in EHR)
2.Revamped
entire visit,
educated each
team member on
role in improving
completeness and
correctness,
patient reminded
to bring
medications or
updated list to
visit, when patient
arrived they were
given a form to
record
medications if they
did not bring
containers or list,
LPN recorded all
four components
of each

Correctness:
Pre-intervention: 59/86 (69%) of
patients agreed to participate
Post-intervention: 61/100 (61%) of
patients agreed to participate
No significant improvement of
correctness (p = 0.442):
Pre-intervention: 14/59 (23.7%)
Post-intervention: 11/61 (18%)

MEDICATION RECONCILIATION

Nassaralla et al.
2009

Quasiexperimental
Before and after
4 adult ambulatory
primary care
internal medicine
clinics
Pre-intervention:
n = 108
LPN intervention:
n = 102
Patient
intervention:
n = 115

31

Completeness of
Med Rec in EHR
(“complete”=
name, dose,
frequency, and
route
documented)
Correctness of
Med Rec in EHR
(“correct”= no
discrepancies in
the name, dose
frequency, or
route, between
the medication list
in EHR and
medications the
patient was taking
at home)
Phone call to
collect
information from
patient

medication,
physician
reconciled and
updated the list,
transcriptionist
checked for
discrepancies
between the
dictation and the
med list in the
EHR
3 phases:
1.Baseline data
2.LPN
intervention:
(a) education
including the
complete and
correct Med Rec
process,
(b) performance
updates including
number and type
of discrepancies
3.Patient
awareness:
(a) called day
before visit
(b) highlighted
paragraph in
reminder letter
than was focused
on bringing

Statistically significant increase in
the number of complete individual
medications and lists (p <. 03):
Complete medication list:
Pre-intervention: 22/108 (20.4%)
LPN-intervention: 46/102 (45.1%)
Patient-intervention: 58/115 (50.4%)
Complete medications:
Pre-intervention: 605/791 (76.5%)
LPN-intervention: 643/759 (84.7%)
Patient-intervention: 781/885
(88.3%)
Correctness:
Participation
Pre-intervention: 61/108 (56%) of
patients in correctness assessment
LPN-intervention: 52/102 (51%) of
patients in correctness assessment
Patient-intervention: 69/115 (60%)
of patients in correctness
assessment
There was a decrease in
correctness from 19/61 (31.2%) in

Level: III
Quality:
High
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Accurate=
complete and
correct

National Institute
for Health and
Care Excellence
(NICE)
2015

SR of SRs of
RCTs, single
RCTs, or
observational
studies (when
RCTs were not
available)
Individuals using
medications

Improved
medication safety

medications to
appointment
(c) brochure in
waiting room
(d) LPN educated
patient on
importance of Med
Rec
(e) given copy of
brochure
(f) reconciled
medications
(g) printed copy
and gave to
patient

Med Rec
completed by a
trained
professional

the pre-intervention phase to 12/52
(23.1%) in the LPN intervention
phase (p < .34)
Patient-intervention increased
correctness from 12/52 (23.1%) in
the LPN intervention phase to 26/69
(37.7%) in the patient intervention
phase (p = .087)
Accuracy significantly improved
from pre-intervention phase to the
patient intervention phase from
11.5% to 29% (p = .014)
Percentage of patients that brought
their medications increased from
13.9% in the pre-intervention phase
to 33% in the patient intervention
phase (p < .001)
Med Rec should be completed at all
transitions of care
In the hospital setting, Med Rec
should be documented within 24
hours of admission and when the
person moves from one setting to
another, for example transfers
between units
In primary care, Med Rec should be
completed on every patient
discharged from the hospital or
seeking care from another facility

Level I
Quality:
High
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Trained professionals were defined
as a pharmacist, pharmacy
technician, nurse, or physician
It is important to involve patients
and their families in the Med Rec
process

Stock et al.
2009

Quasiexperimental
Before and after
11 primary care
clinics

Number of
inaccurate EHR
medication lists

5 components:
1. Asked patient to
bring medications
to visit during
appointment
reminder call
2. Clinic personnel
reviewed
medications with
the patient at start
of visit
3. Medication list
was reconciled
with EHR and
changes were
documented
4. New
prescriptions were
checked for
interaction/conflict,

Med Rec should be performed using
a designated process, in which the
medications are recorded in an EHR
or on paper
Baseline: 20% of the reviewed
charts has discrepancies between
the EHR and the patient’s
medication list.
Post-intervention: 50% of the
reviewed charts has discrepancies
between the EHR and the patient’s
medication list
Number of discrepancies per
medication list was reduced
significantly (no statistical data
provided)

Level: III
Quality:
Poor
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with an updated,
reconciled
medication list

Varkey et al.
2007

Quality
Improvement
Quasiexperimental
Before and after
104 primary care
patients
Phase I (preintervention):
n = 54
Phase II (postintervention):
n = 50

5. A printed paper
copy of the
reconciled
medication list was
given to the
patient
Number of
Phase I:
medication
(pre-intervention,
discrepancies
standard care)
between what the Medication history
patient was taking was documented
and what the
in the EHR by the
EHR stated the
provider
patient was taking
Phase II: 2 levels
Severity of
1. Patient level:
discrepancies:
(a) reminder letter
Minor- incomplete to bring
information in
medication bottles
medication order, to next visit was
unavailable or
mailed to the
inappropriate
patient
dosage form,
(b) the patient
non-formulary
verified and
drug, or unusable corrected the
abbreviation
medication list in
Significant- high
the EHR
dosage (1.5-4
time normal) of
2. Provider level:
drug with low
(a) education
therapeutic index, including
drug dosage too
significance and

Patients brought their medication
bottles or an updated list:
Phase I: 3/54 (5%) of patients
Phase II: 26/50 (52%) of patients
Visits with some EHR medication
discrepancy (p = .0134):
Phase I: 53/54 (98.2%)
Phase II: 42/50 (84%)
Medication lists with discrepancy
(when prescription medications only
considered) (p = .005):
Phase I: 48/54 (88.9%)
Phase II: 33/50 (66%)
Total individual prescription
medications with discrepancies:
Phase I: 177/200 (88.5%)
Phase II:79/161 (49.1%)
Incorrect or missing route was the
most common missing information
Average number of discrepancies
among herbal and OTC
medications:

Level: III
Quality:
Good
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low for patient’s
condition,
incorrect dual
drug therapy for
single condition,
inappropriate
dosage interval,
or omission from
medication order
Serious- route of
administration
could lead to
toxicity, low
dosage of drug
for serious
disease, drug
could worsen
patient’s
condition,
misspelling that
could lead to
dispensing
incorrect drug
Potentially lethalhigh potential for
life-threatening
adverse
reactions,
potentially
lifesaving drug at
a dosage that is
too low, high
dosage of drug
with low
therapeutic index

method of the Med
Rec
(b) audit feedback
weekly via email
with examples of
errors and
individual data
compared to
others

Phase I: 112/147 (76.2%)
Phase II: 34/101 (33.7%)
Severity:
Minor
Phase I: 75%
Phase II: 82.9%
Significant
Phase I: 24%
Phase II: 17%
Serious
Phase I: 0.3%
No lethal discrepancies in Phase I
or Phase II

MEDICATION RECONCILIATION
Weingart et al.
2007

Quasiexperimental
Before and after
Quality
Improvement
2 adult outpatient
oncology clinics
1 pediatric
outpatient
oncology clinic,
data cannot be
stratified
Standard care
group:
n = 54
Intervention group:
n = 50

36
Number of
medication lists
reconciled
Errors and
omissions per
patient and per
prescription
Pharmacist time
required to collect
Med Rec lists and
correct EHR’s

Copy of
medication list and
a one page cover
letter
Standard care
group: list was
collected prior to
appointment
Intervention group:
(a) took updated
list into
appointment
(b) brochure sent
about medication
safety
(c) printed copy
from EHR given to
patient at visit
(d) asked patient
to update,
including OTC,
vitamins, and
supplements
(e) physician
reviewed the list
with the patient
(f) the physician or
pharmacist
updated the EHR
(g) printed
updated med list
given to patient

The number of medication lists
reconciled per month increased
>400% from 300-400 per month in
the pre-intervention phase to 15002000 per month in the postintervention phase
53,040 changes to 168,475 listed
drugs (31 changes per 100
medications) (81% of patients list
included at least one error or
omission)
257 hours/year (0.6 full-time
equivalents of a pharmacist’s time)
Medication list that had at least one
patient identified correction (p <
.001):
Standard care group: 1/47 (2%)
Intervention group: 38/42 (90%)
Number of physician made changes
per patient (p < .001):
Standard care group: 0.1 changes
per patient
Intervention group: 4.3 changed per
patient

Level III
Quality:
Good
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Note. MRE= medication reconciliation errors, ADE= adverse drug event, EHR= electronic health record, Med Rec= medication
reconciliation, BPMH= best possible medication history, ER= emergency room, PCP= primary care provider, LPN= licensed practical
nurse, SR= systematic reviews, RCT= randomized controlled trials, OTC= over-the-counter.
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Construction of Evidence-based Practice
The literature was examined and only literature relevant to the topic was included. The
inclusion and exclusion criteria guided the systematic literature review. Articles that were
deemed applicable were then leveled and appraised to ensure that the best Med Rec practice
was identified. A single article was found that examined Med Rec in the pediatric outpatient
oncology setting (Weingart et al., 2007). The CPG found addressed Med Rec in any setting and
was included as a baseline recommendation. The remaining literature was divided into three
main groups: pediatric inpatient studies, adult outpatient studies, and adult inpatient studies.
The pediatric inpatient and adult outpatient studies became the focus of the literature review, as
their setting or population were similar to the project site. Adult inpatient studies were not
included because the setting and the population differed from the project site’s setting and
population. Also, the Med Rec process and outcomes were not applicable to this project.
Pediatric and adult outpatient oncology study and CPG. As discussed previously, a
minimal amount of literature, examining the implementation or improvement of the Med Rec
process, in the pediatric outpatient setting was discovered. The CPG, along with the study that
examined improving the Med Rec process, in both a pediatric and an adult outpatient oncology
setting are discussed (AHRQ, 2015; Weingart et al., 2007).
Level I evidence. In 2015, the National Institute for Health and Care Excellence (NICE)
developed a CPG entitled “Medicines Optimization: The Safe and Effective Use of Medicines to
Enable the Best Possible Outcomes.” The guideline is based on a systematic review of SRs of
RCTs, single RCTs, or observational studies (when RCTs were not available). The guideline is
applicable to “all children, young people, and adults using medications,” with a goal of improving
medication safety (AHRQ, 2015, p. 1). The guideline recommends that Med Rec be completed
by a trained professional, at all transition of care. A trained professional was defined as a
pharmacist, pharmacy technician, nurse, or physician. The CPG formulated many conclusions,
the conclusions applicable to the project have been reviewed. The guideline emphasizes the
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importance of involving patients and their families in the Med Rec process. Also, the CPG
recommends Med Rec be performed using a designated process, in which medications are
recorded in an EHR or on paper (AHRQ, 2015).
Level III evidence. A quasi-experimental, before and after, study was conducted at one
pediatric outpatient oncology clinic and two adult outpatient oncology clinics (Weingart et al.,
2007). Unfortunately, the data could not be stratified from the information provided. The
standard care group (n = 54) received a copy of their medication list and were asked to revise
the medication list. The list was then collected prior to the physician aspect of the appointment.
In contrast, the intervention group (n = 50) was sent a brochure about medication safety. Upon
arriving to their visit, the patient was given a printed medication list from the EHR and asked to
update the list. The patient was instructed to include: OTC medications, vitamins, and
supplements. During the visit, the physician reviewed the list with the patient, and the physician
or pharmacist updated the EHR. Finally, the updated medication list was printed and given to
the patient, prior to the end of the visit (Weingart et al., 2007).
The number of medication lists that were reconciled, along with the errors and omissions
per patient and per prescription were recorded. The number of medication lists reconciled
increased greater than 400% from 300-400 per month in the pre-intervention phase to 1,5002,000 per month in the post-intervention phase. There were 53,040 changes to 168,475 listed
drugs (31 changes per 100 medications) and 81% of patients’ lists included at least one error or
omission. Two-hundred and fifty seven hours per year (0.6 full-time equivalents of a
pharmacist’s time) was needed to collect the Med Rec lists and correct the EHR. The number of
medication lists, that had at least one patient identified correction, increased from 2% (one of
47) in the standard care group to 90% (38 of 42) in the post-intervention group (p < .001). The
number of ‘physician made’ changes per patient increased from 0.1 changes per patient in the
standard group to 4.3 changes per patient in the intervention group (p < .001) (Weingart et al.,
2007).

MEDICATION RECONCILIATION

41

Pediatric inpatient studies. The evidence, included in this review of literature, that
focused on the pediatric inpatient population are of particular importance. Specifically, they
discuss the need for Med Rec in pediatrics. Med Rec should be viewed as a way to decrease
the incidence of medication errors. Pediatric patients are at an increased risk for medication
errors; and therefore, techniques for possible reduction in errors should be taken seriously. The
pediatric inpatient evidence focused on both the completion of the Med Rec process and the
accuracy of the Med Rec. One Level III study, one Level IV study, and one Level VII review of
literature were included and are discussed at this time.
Level III evidence. Hron et al. (2015) conducted a study that sought to “measure the
impact of electronic medication reconciliation implementation on reports of admission
medication reconciliation errors (MREs)” (p. 314). The quasi-experimental, quality improvement,
time series was conducted at a tertiary care children’s hospital and included all patients
admitted in one year. The outcome of measure was the rate of non-intercepted admission
MREs identified, by a voluntary reporting system. The severity of the MREs was ranked on a
zero to five scale: zero was assigned to any intercepted potential ADE that did not reach the
patient; one was assigned to any non-intercepted potential ADE that reached the patient and no
condition change occurred; two was any minor ADE; three was any moderate ADE; four was
any major ADE; and five was any catastrophic ADE. The intervention implemented was an EHR
tool that displayed the pre-admission medication list beside the admission medication orders.
Also, Med Rec compliance was reported to the inpatient units (Hron et al., 2015).
The Med Rec tool compliance was found to be <3% pre-intervention and 83.8% postintervention. Pre-intervention there were 4.1 Med Rec errors per 1,000 admissions and postintervention there were 2.0 errors per 1,000 admissions. There was also a statistically significant
decrease (53%) in rate of MRE’s post intervention (p = .02; 95% CI [26, 87]). The risk of
reported ADEs related to admission Med Rec was significantly lower post intervention (R2 = .24;
p < .001; 95% CI [0.11, 0.53]). Pre-intervention there were 1.7 intercepted potential ADEs, per
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1,000 admissions and 1.4 post-intervention. There were 2.3 non-intercepted potential ADEs, per
1,000 admissions pre-intervention and 1.5 post-intervention. Minor ADEs were reported as 1.7,
per 1,000 admissions pre-intervention and 0.4 post-intervention. Moderate ADEs were 0.1, per
1,000 admissions both pre- and post-intervention. During the study period there were no major
or catastrophic ADE’s pre- or post-intervention. Overall, the Med Rec process produced a
statistically significant decrease in the reported number of non-intercepted admission MREs,
after an electronic Med Rec process was implemented (Hron et al., 2015).
Level IV evidence. A prospective cohort study, by Huynh et al. (2016), conducted in
four pediatric hospitals in the United Kingdom, examined the incidence of unintended
medication discrepancies, in pediatric inpatients. The authors included patients (n = 244) if they
were prescribed one long term medication. They excluded patients if they were: > 19 years of
age, had no caregiver present, no drug list was available, or if they were admitted outside of
routine hours. Medication discrepancies, defined as a difference between the patients preadmission medication list when compared to initial admission medication orders, were totaled
and classified as intentional or unintentional. The severity of unintentional discrepancies was
further classified as: class 1 potentially minor, class 2 potentially moderate, and class 3
potentially severe. Finally, the time to obtain information was recorded. In this study, a clinical
pharmacist: (1) interviewed the caregiver, (2) called the PCP to obtain the patients medication
record, (3) recorded the patients medications brought from home, and (4) examined the initial
admission medication orders. There was no previous Med Rec process in place at this site
(Huynh et al., 2016).
Overall, there were 1,004 individual prescriptions and 582 medication discrepancies
(58%) that affected 203 patients (83%). Two hundred and nine of those discrepancies were
unintentional and affected 109 patients (45%). Two hundred and seventy-seven of the
discrepancies were intentional, and 96 were determined to be trivial or related to nutrition.
Twenty-two percent of the unintentional medication discrepancies were class 1; 50% were class
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2; and 28% were class 3. The total time to collect the information ranged from six to 144
minutes (Mdn = 24, IQR 17-40) (Huynh et al., 2016).
The authors found that the parents/caregivers were the most accurate source, with 81%
correct when compared to the pharmacist completed regimen. The PCP was 70% correct,
followed by the medications present at the visit with 56% correct. The medications were brought
with the patients at 38.5% of admissions. The authors postulated that Med Rec decreased the
risk of harm from unintended medication discrepancies. Parents were found to be the most
sensitive/accurate source of information, followed by the PCP, and then the medications present
(Huynh et al., 2016).
Level VII evidence. A review of literature, without meta-analysis, conducted by Huynh et
al. (2013), focused on the rate of medication discrepancies in pediatric patients at transitions of
care and specifically what Med Rec interventions were being used. The authors searched
numerous databases including: PubMed, OVID EMBASE, ISI Web of Science, ISI Biosis,
CINHAL, and OVID International Pharmaceutical Abstracts. Inclusion criteria included: < 18
years of age upon admission to the hospital, transfer, or discharge, and a reported Med Rec
intervention. Exclusion criteria included: mixed pediatric and adult data that could not be
stratified, outside the pediatric age limit, not original research, and studies that did not clearly
define discrepancies or interventions (Huynh et al., 2013).
In total, ten articles were included in the review: six prospective observational studies
and four retrospective observational studies. There were seven full articles and three non-peer
reviewed articles. The outcomes of focus were medication discrepancies, at pediatric transitions
of care, and the clinical significance of the identified discrepancies. The majority of
measurements occurred upon inpatient hospital admission. The slight variance in the outcome
measurement limits the generalizability to other populations (Huynh et al., 2013).
The review of literature uncovered a variety of interventions that were used in an effort to
increase Med Rec accuracy. The variety of interventions did not lead to definitive conclusions,
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regarding the best practice to increase Med Rec accuracy. The authors concluded that there
was limited high quality evidence related to Med Rec, at pediatric transitions of care. Further
research is needed to fully understand the most beneficial Med Rec process in pediatrics
(Huynh et al., 2013).
Adult outpatient studies. Four of the sources, included in this review of literature, all
Level III, focused on Med Rec in the adult outpatient setting. Common themes were found in
these adult outpatient studies. Themes included (a) a Med Rec process that is complete,
correct, and accurate, (b) the importance of a multidisciplinary approach, and (c) an intervention
that included both patient and provider.
Level III evidence. Nassaralla et al. (2007) conducted a quasi-experimental, before and
after, study in an adult primary care, internal medicine clinic. Pre-intervention there were 65
participants, post-intervention there were 100 participants, and during the sustainability phase
there were 65 participants. The outcome of measure was the completeness of Med Rec in the
EHR. Completeness was defined as a medication having the name, dose, frequency, and route
of administration documented in the EHR. Also, the correctness of the Med Rec in EHR was
assessed. Correctness occurred when there were no discrepancies in the name, dose,
frequency, or route of administration between the medication list in EHR and the medications
the patient was taking at home. The correctness was evaluated by contacting the patients via
phone and verifying the current medication regimen. Finally, a Med Rec was deemed accurate if
it was both complete and correct (Nassaralla et al., 2007).
Prior to the intervention, the authors reviewed the Med Rec process and shared the
collected baseline data, with team members. The intervention consisted of two steps. In the first
step, all the team members were educated, regarding what constitutes a complete and correct
medication list. The results of the pre-intervention data were shared with the nurses and
physicians. The same rooming process was used for all patients. The rooming process
consisted of the LPN obtaining and documenting the medication history in the EHR. The second
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step was to revamp the entire patient visit. First, team members were educated on their role in
the Med Rec process. The patients were reminded to bring their medications or an updated list
to their visit. When the patient arrived they were given a form to their record medications, if they
had not brought their medication containers or a list. The LPN recorded all four components of
each medication. Then the physician reconciled and updated the list. Finally, the transcriptionist
checked for discrepancies between the dictation and the EHR medication list (Nassaralla et al.,
2007).
The authors found a significant increase in the documentation of the dose and route. In
the pre-intervention phase, 27.4% of medications charted were missing a dose, postintervention that percentage had decreased to 21.7 (p < .03). During, the sustainability phase
the percentage of medications without a dose charted was 12.9%, this was a statistically
significant improvement from the post-intervention phase (p < .001). In the pre-intervention
phase 69% (59 of 86) of the patients agreed to participate in the correctness interview. Postintervention 61% (61 of 100) agreed to participate. There was no significant improvement of
medication list correctness found pre-intervention (23.7%), when comparted to the postintervention phase (18%) (p = .442) (Nassaralla et al., 2007).
The second Level III evidence was a quasi-experimental, before and after, study
(Nassaralla et al., 2009). The setting was four adult ambulatory, primary care, internal medicine
clinics. The intervention consisted of three phases: pre-intervention/baseline data collection (n =
108), an LPN intervention phase (n = 102), and a patient awareness intervention phase (n =
115). The completeness, correctness, and accuracy of the medication list, where the outcomes
examined. Completeness was defined as a medication having the name, dose, frequency, and
route of administration documented in the EHR. Correctness occurred when there were no
discrepancies in the name, dose, frequency, or route of administration between the medication
list in EHR and the medications the patient was taking at home. The correctness was evaluated
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by contacting the patients via phone and verifying the current medication regimen. Finally, a
Med Rec was deemed accurate if it was both complete and correct (Nassaralla et al., 2009).
First, the authors collected pre-intervention, baseline data on 108 patients. The data
included the completeness, the correctness, and accuracy of the medication list. The authors
then provided an LPN intervention. The LPN intervention consisted of education including the
complete and correct Med Rec process and performance updates including the number and
type of discrepancies. The patient awareness intervention consisted of: (a) calling the patient
the day before a their visit and reminding them to bring their medications with them, (b)
highlighting the paragraph in the reminder letter that focused on bringing medications to the
appointment, (c) a brochure in waiting room that emphasized medication safety importance, (d)
the LPN educated the patient on the importance of Med Rec (e) a copy of the brochure was
given to the patient (f) the medications were reconciled, and (g) a printed copy was given to the
patient (Nassaralla et al., 2009).
There was a statistically significant increase in the number of medications and lists that
were completed (p < .03). Pre-intervention 20.4% of medication lists were complete, after the
LPN intervention 45.1% of lists were complete, and after the patient awareness intervention
50.4% of lists were complete. Pre-intervention 76.5% of medications documented were
complete, after the LPN intervention 84.7% of medications documented were complete, and
after the patient awareness intervention 88.3% of medications documented were complete. The
participation in the assessment of correctness was 56% pre-intervention, 51% after the LPN
intervention, and 60% after the patient awareness intervention. From the pre-intervention to
LPN intervention statistically significant improvement was not shown. Actually, there was a
decrease in correctness from 31.2% in the pre-intervention phase to 23.1% in the LPN
intervention phase (p < .34). The authors speculated that this is a result of the small number of
participants that agreed to participate in the correctness assessment, or possibly a result of the
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pressure LPNs felt to complete the medication list, disregarding the correctness (Nassaralla et
al., 2009).
The patient participation component increased correctness from 23.1% in the LPN
intervention phase to 37.7% in the patient intervention phase (p = .087). Accuracy was
significantly improved from the pre-intervention phase to the patient intervention phase from
11.5% to 29% (p = .014). The percentage of patients that brought their medications increased
from 13.9 % to 33% in the pre-intervention phase to the patient intervention phase (p < .001).
Overall, the increased team member and patient participation lead to an increase in the
completeness of medications documentation and medication lists (Nassaralla et al., 2009).
A quasi-experimental, before and after, study took place in 11 primary care clinics (Stock
et al., 2009). The number of inaccurate EHR medication lists and medication accuracy were
measured. There were five components to the Med Rec implementation. The first step was
asking the patient to bring their medications to their visit. This reminder occurred during the
appointment reminder call. Secondly, the clinic personnel reviewed the patient’s medications at
the start of the visit. Next, the medication list was reconciled in the EHR and changes were
documented. The fourth step was that new prescriptions were checked for interaction or conflict
with the updated reconciled medication list. Finally, a printed paper copy of the reconciled
medication list was given to the patient (Stock et al., 2009).
Despite the five components of the Med Rec process being implemented, the authors
noted that “it was not stipulated that the implementation needed to be the same at each practice
setting, thereby allowing practices to design a process that took into account their personnel
and resources without affecting the agreed-on outcome of more accurate medication lists”
(Stock et al., 2009, p. 276). Stock et al. (2009) concluded that the Med Rec process showed a
“substantial increase in the number of accurate medication lists, with fewer discrepancies
between what the patient is taking and what is recorded in the EMR” (p. 271). Prior to the
intervention 20% of the reviewed charts has discrepancies between the EHR and the patient’s
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medication list. Post-intervention 50% of the reviewed charts has discrepancies between the
EHR and the patient’s medication list. No additional data could be extrapolated from the article
(Stock et al., 2009).
The fourth Level III source of evidence focused on Med Rec in the adult outpatient
setting. The authors conducted a quasi-experimental, before and after study, that involved 104
primary care patients (Varkey et al., 2007). The study was divided into Phase I (pre-intervention,
n = 54) and Phase II (post-intervention, n = 50). The number of medication discrepancies
between what the patient was taking and what the EHR stated the patient was taking were
recorded. The severity of the discrepancies were classified as minor, significant, serious, or
potentially lethal. During Phase I, standard care was provided to the patients, in which the
medication history was documented in the EHR by the provider. In Phase II, there was a patient
level intervention and a provider level intervention. The patient level intervention included: (a) a
mailed, reminder letter to bring medication bottles to the next visit and (b) verification and
correction of the medication list in the EHR by the patient. The provider level intervention
included: (a) education including the significance and method of Med Rec and (b) audit
feedback weekly via email, with examples of errors and individual data compared to others
(Varkey et al., 2007).
Five percent of patients (3 of 54) brought their medication bottles in Phase I, as
compared to 52% (26 of 50) in Phase II. In Phase I, 98.2% (53 of 54) of visits had some EHR
medication discrepancy and in Phase II 84% (42 of 50) had a discrepancy (p = .0134). When
only prescription medications were considered, the medication lists with discrepancies were
88.9% (48 of 54) in Phase 1 and 66% (33 of 50) in Phase II (p = .005). The number of
discrepancies per patient decreased from 5.24 in Phase I to 2.46 in Phase II. The total individual
prescription medications with discrepancies was 88.5% (177 of 200) in Phase I and 49.1% (79
of 161) in Phase II. Incorrect or missing route was the most common missing information. The
average number of discrepancies among herbal and OTC medications was 76.2% (112 of 147)

MEDICATION RECONCILIATION

49

in Phase I and 33.7% (34 of 101) in Phase II. Seventy-five percent of the discrepancies were
minor in Phase I and 82.9% were in Phase II. The percentage of significant discrepancies
decreased from 24% in Phase I to 17% in Phase II. In Phase I, there was one serious
discrepancy and no lethal discrepancies in either phase (Varkey et al., 2007). According to
Varkey et al. (2007), “a multifaceted intervention including various members of the health care
provider team and the patient is crucial to enhancing medication reconciliation in the outpatient
setting” (p. 291).
Synthesis of Critically Appraised Literature
The synthesized literature provided common themes, in regards to the Med Rec
process, measureable outcomes, and interventions. All the evidence emphasized the
importance of having a standardized Med Rec process that is clear and communicated to all
team members and patients. The outcome used most frequently in the literature was the
assessment of the number of medication discrepancies (Hron et al., 2015; Huynh et al., 2013;
Huynh et al., 2016; Stock et al., 2009; Varkey et al., 2007; Weingart et al., 2007). Although, the
evidence by Nassaralla et al. (2007) and Nassaralla et al. (2009) used different terminology
(completeness, correctness, and accuracy) the idea of monitoring the number of discrepancies
was still present. Another common theme in the literature related to the number of medication
discrepancies was the assignment of severity (Hron et al., 2015; Huynh et al., 2013; Huynh et
al., 2016; Varkey et al., 2007). Classifying the severity was in an effort to assess the possible
adverse outcome had the discrepancy not been identified.
In addition to there being common measurable outcomes, there were common
interventions mentioned. In three of the four adult outpatient studies, the intervention had two
components: a patient component and a provider component (Nassaralla et al., 2007;
Nassaralla et al., 2009; Varkey et al., 2007). The patient component generally consisted of: (a) a
reminder to bring their medications to the visit, (b) a brochure or letter emphasizing the
importance of medication safety and reconciliation, and (c) education about the Med Rec
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process. The provider component generally consisted of: (a) education regarding the
importance of the Med Rec process, (b) specific role assignment in the process, and (c)
individual updates of Med Rec compliance and accuracy (Nassaralla et al., 2007; Nassaralla et
al., 2009; Varkey et al., 2007). The one source that focused on both the pediatric and adult
outpatient population had a similar intervention (Weingart et al., 2007).
Many healthcare organizations, in both the inpatient and outpatient setting, are seeking
ways to implement best practice and ensure patient medication safety. From the literature, one
realizes that Med Rec has a large impact on medication safety. With the improvement of an
existing Med Rec process, medication safety can improve. Clear delineation of the Med Rec
process is the first goal in providing evidence-based care. Measuring and monitoring the
number of medication discrepancies will give the team members a sense of whether the Med
Rec process intervention is, in fact, meeting goals. The severity of the discrepancies sheds light
into the potential ADE’s that occurred or could have occurred. Finally, an intervention that
includes both patients and healthcare providers is supported and recommended repeatedly in
the literature.
Best Practice Model Recommendation
After appraisal and synthesis of the current literature, the importance of not only
measuring medication discrepancies, but preventing them became clear. The literature guided
the PL to the overall outcomes to be measured and intervention themes. Although, the reviewed
studies were not conducted in both the correct setting and population, the information and
recommendations can be tailored to the pediatric hematology/oncology outpatient population.
The outcome chosen for this EBP project, measurement of medication discrepancies and their
severity, was commonly used in the evidence. The intervention chosen for this EBP project was
based on the adult outpatient settings. These studies had current Med Rec processes in place,
as did the project site, and the process was more similar to the project site than the pediatric
inpatient evidence. The intervention was both patient and team member focused. It was
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anticipated that implementing an intervention, which involved a standardized process, and
patient and team member education would decrease the number and severity of medication
discrepancies. Also, a decrease in the number of medication errors reported was anticipated.
The Kotter Model of Change was useful in implementing the change, or intervention. The
model was helpful in laying the foundation and framework, in a setting in which change was
greatly resisted. Kotter’s Model of Change emphasizes all team members working together to
better the clinical environment, this is similar to the literatures emphasis on the multidisciplinary
approach to Med Rec and the positive impact and role patients play in the process. The Stetler
EBP Model was appropriate in aiding the implementation of evidence into clinical practice, with
the goal of improving care provided to patients.
In order to assess the current climate and belief regarding the Med Rec process, a
survey was conducted prior to implementation of the intervention and at the conclusion of the
EBP project. The survey was designed by the PL and completed by team members. Baseline
data from the EHR was collected by the physicians and PL. The number, type, and severity of
the medication discrepancies and the number of reported medication errors was collected.
These data were then collected again after the intervention took place. The definitions of
completeness, correctness, and accuracy found in the literature (Nassaralla et al., 2007;
Nassaralla et al., 2009) were used to evaluate individual medications and the overall medication
list. The severity of the discrepancies was measured using the class 1, 2, and 3 scale (Huynh et
al., 2013; Huynh et al., 2016). The outcomes would have ideally been collected using the EHR;
however, this was not be possible. Collecting the data from the EHR was not possible because
the EHR did not provide the ability to see who made changes to the medication list, what
changes were made, and when the changes were made. Discussions with the IT department
were helpful in answering this question. Therefore, the data were collected by the physicians at
the project site, who conducted the last step in the Med Rec process, and also by the PL. The
PL was responsible for educating the physicians on appropriate data collection technique. The
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medication error information was collected using the sites computer system, where medication
errors are voluntarily reported.
The literature, conducted in the adult outpatient setting, was the basis for the proposed
intervention (Nassaralla et al., 2007; Nassaralla et al., 2009; Varkey et al., 2007; Weingart et al.,
2007). The project intervention included two components: a patient component and a team
member component. The patient component consisted of a verbal call reminder to bring
medications during the visit. This reminder was given by the unit assistants who makes the
reminder phone calls. Also, a handout, created by the PL, emphasizing the importance of
medication safety and reconciliation was provided to the patients during their office visit. Patient
education regarding their role in the Med Rec process and their intricate involvement in Med
Rec was reviewed by the MA or nurse, during their visit. At the project site, the team member
component included unit assistants, MAs, and registered nurses. The team member component
included education regarding the importance of the Med Rec process and the specific role
assignment in the process. Also, updates regarding the Med Rec completeness, correctness,
and accuracy were distributed to team members during the post-intervention phase, via email.
How the Best Practice Model will Answer the Clinical Question
The reviewed and synthesized literature offered an answer to the clinical question: Will a
standardized, collaborative Med Rec process that is communicated to all team members and
patients decrease the number of medication discrepancies? The implementation of the evidence
based intervention was guided by the Kotter Model of Change and the Stetler EBP Model. To
assess the impact of the proposed intervention, the number, type, and severity of medication
discrepancies and the total number of medication errors reported was examined. The results of
this project determined if the intervention, both patient and team member, reduced the number,
type, and severity of medication discrepancies and medication errors. It was hoped that a
reduction in medication discrepancies would ultimately improve patient medication safety, in a
pediatric outpatient hematology/oncology clinic.
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CHAPTER 3
IMPLEMENTATION OF PRACTICE CHANGE
After identification of a clinical problem and synthesis of the literature, planning
implementation of a practice change was of utmost importance. As discussed previously, in
Stetler’s EBP Model the first three stages lead up to the fourth stage: application/translation.
Stetler’s Model emphasized the importance of planning prior to implementing the best evidence
based practice. The ultimate goal of implementing this EBP project was to improve pediatric
hematology/oncology medication safety, by implementing the best Med Rec process.
In order to protect participants and ensure their ethical treatment, IRB approval from
both Valparaiso University and the clinical agency was obtained. Throughout the EBP project
time frame, the PL monitored the practice change. The PL monitored the Med Rec process and
also ensured participant safety and confidentiality were maintained. Chapter 3 details the
methods that were used to implement this EBP project. The specific items discussed include:
participants and setting, outcomes, intervention, planning, data, and protection of human
subjects.
Participants and Setting
This EBP project took place in a pediatric hematology/oncology outpatient clinic in the
Midwest. The pediatric hematology/oncology outpatient clinic provides services Monday through
Friday and offers access an on-call physician 24 hours a day, seven days a week. The clinic, on
average, has 2,500 patient visits per year. The Med Rec process occurs at every patient visit in
which a physician evaluates the patient. The process spans from the patient’s arrival to the
clinic, to the conclusion of the visit. The patient and the following team members are included in
the Med Rec process: unit assistants, MAs, registered nurses, and physicians. The goal was to
standardize the Med Rec process and improve Med Rec accuracy. The improvement in
accuracy required a combined effort, from all patients and all team members. It was the PL’s
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hope that all team members would be available for the team component of the intervention and
would be included in the Med Rec process improvement. However, the physicians were not
present for the team member component of the intervention. The lead physician was educated
by the PL regarding the change in process and then the lead physician educated the other
physicians. It was also the PL’s hope that all patients would realize the benefit of their
involvement in the Med Rec process.
Outcomes
There were several outcomes assessed during the project implementation. In order to
assess the current climate and beliefs regarding the Med Rec process, a survey was conducted
prior to implementation of the intervention. A survey was also used to assess the climate and
beliefs regarding the Med Rec process at the conclusion of the project (see Appendices A and
B). The surveys were designed by the PL.
Baseline data from the EHR were collected to examine the number, type, and severity of
medication discrepancies. These baseline data collections occurred for three weeks prior to the
intervention and were collected by both the physician and the PL. The number, type, and
severity of medication discrepancies were collected again by the physicians and the PL after the
intervention took place (see Appendices C and D). The definitions of completeness,
correctness, and accuracy found in the literature (Nassaralla et al., 2007; Nassaralla et al.,
2009) were used to evaluate individual medications and the overall medication list. In order for
the PL to collect correctness data the patients/caregivers were contacted via telephone to
assess whether what was documented in the EHR was in fact what the patient was taking at
home. Correctness data were collected on half of the patients the physicians collected
medication discrepancy data on. Random sampling was used to select the patients. The
severity of the discrepancies were measured using the class 1, 2, and 3 scale found in the
literature. Class 1 was defined as a potentially minor error. Class 2 was defined as a potentially
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moderate error. Class 3 was defined as a potentially severe error (Huynh et al., 2013; Huynh et
al., 2016).
Finally, the number of voluntarily reported medication errors was assessed. The
medication error reports were collected from the computer incident report system. The number
of reports pre and post-intervention were compared, as well as examination of the medication
error reports, during the same time the previous year.
Intervention
The overall goal of this EBP project was to improve medication safety in a pediatric
outpatient setting. This medication safety improvement was facilitated by enhancement of the
Med Rec process. The intervention was based on synthesis of the literature. The intervention
had two components: a patient/caregiver component and a team member component. The
patient/caregiver component included three elements: (1) prompting caregivers during the visit
reminder call to bring the patient’s medications to the visit, (2) a handout given to the patient
during their visit that emphasized the patient’s role in the Med Rec process (see Appendix E),
and (3) individual education regarding the Med Rec process during the patient’s visit.
The team member component included: (1) education regarding Med Rec, (2)
development of a standardized Med Rec process, and (3) medication discrepancy feedback via
email. Team members attended an educational meeting, in which a PowerPoint® was
presented (see Appendix F). The information was presented during a monthly team member
meeting. The PL introduced the project topic and details to the team members. The
PowerPoint® included: background Med Rec information, data from the literature, project
intervention information, and baseline data collected from the clinic. A short Med Rec
informational handout was given to team members as a reminder (see Appendix G). The
baseline data included the number, type, and severity of the medication discrepancies and the
anonymous survey results. During this meeting, the current Med Rec process was reviewed. A
new standardized process was outlined and agreed upon by all team members.
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Planning

There were two phases of this EBP project. The first phase consisted of baseline data
collection, prior to the intervention. During Phase 1, the pre-intervention survey was distributed
and completed by team members (see Appendix A). Also, pre-intervention data were collected.
This data included the number of medication discrepancies. The discrepancies were classified
by type and severity. The physicians collected completeness, correctness, and accuracy data
from the EHR. The PL collected demographic, completeness, correctness, and accuracy data
from the EHR and telephone conversation. Data from the Physician Medication Reconciliation
Tracking Form was coded by the PL, in an effort to promote patient information protection (see
Appendix H). Phase 1 data collection lasted three weeks. One and half weeks were allowed to
analyze the data and add the data to the educational PowerPoint®.
Phase 2 began immediately following the intervention. The intervention began with the
educational meeting, facilitated by the PL. During Phase 2, the team members completed a data
collection form on all patients (see Appendix I). This form served as a reminder and a means to
monitor key components of the Med Rec process. Phase 2 data were collected for three weeks.
Similar to Phase 1, data included the number of medication discrepancies. The discrepancies
were further classified by type and severity. Phase 2 data were collected by the clinic team
members, physicians, and PL. The PL was frequently available to educate and encourage
process compliance. At the half way mark of Phase 2, an email was sent from the PL to the
team members detailing the overall number, type, and severity of the medication discrepancies
found by the physicians and PL. The email also included words of encouragement and
acknowledgement of the difficulty of change. This email update was in an effort to improve team
member involvement and the consistent use of the standardized process.
At the completion of Phase 2, a post-intervention survey, designed by the PL, was
completed by all team members (see Appendix B). This was in an effort to assess team
member’s perception of the revised Med Rec process. Also, at the end of Phase 2, the PL
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collected the voluntary medication error reports that were completed during the length of the
project. The length of Phase 1 and 2 combined was eight weeks.
Data
The survey, used during Phase 1 and Phase 2, collected minimal demographic data
from the team members, including age, race, gender, level of education, current employment
status, and years of practice in the project setting (see Appendices A and B). The survey
assessed the team member’s beliefs surrounding the efficiency and accuracy of the current Med
Rec process. Based on the results of the survey, a collaborative effort was made to standardize
the Med Rec process. The standardized process included role delegation for each process step.
During Phase 2, team members were required to complete a form tracking the important
components of the standardized Med Rec process (see Appendix I). This form served as a
reminder to team members of the new standardized Med Rec process.
During Phase 1 and 2 the number, type, and severity of the medication discrepancies
were collected by the physicians and the PL. Medication discrepancy included completeness,
correctness, and accuracy. A medication in the EHR was considered complete if the name,
dose, frequency, and route of administration were specified. A medication was considered
correct if there were no discrepancies between the medication list in the EHR and the
medications the patient was taking at home. Medication discrepancy data were collected by the
physicians on the patients seen in the clinic. The PL also verified the patient medication list
using the EHR and calling the patient to verify correctness. Half of the patients that the
physicians collected discrepancy data on were called in an effort to collect correctness data.
The data collection forms used by the physicians and the PL were coded to ensure patient
confidentiality (see Appendices C and D).
Finally, the PL assessed the number of medication errors reported during duration of the
project. The medication error reports completed during the project time were compared to the
same time frame the year before.
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Measures
The reliability and validity of the data measures used in an EBP project are important to
discuss. Measures are considered reliable when consistent measurements are obtained over
time (Dougherty, 2015). Validity addresses whether the measurement measures what it is
supposed to measure (Brewer & Alexandrov, 2015). Internal and external validity are two types
of validity. Internal validity can be defined as “the degree to which it can be inferred that the
experimental intervention (independent variable), rather than uncontrolled, extraneous factors,
is responsible for observed effects” (Polit & Beck, 2012, p. 731). External validity can be defined
as “the degree to which study results can be generalized to setting or sample other than the one
studied” (Polit & Beck, 2012, p. 727).
The outcomes that were measured in this EBP project have been used in many studies,
examining the accuracy of Med Rec. These outcomes were selected by the PL in an effort to
obtain similar information as past studies supporting internal validity. The same process was
used to collect the number, type, and severity of medication discrepancies, in both Phase 1 and
Phase 2. The data collection was done by one person, the PL, in order to support reliability.
EHR data and telephone calling were chosen as the data sources, opposed to the PL
directly observing the completion of the Med Rec process. The use of EHR data were in an
effort to decrease the impact that the presence of the PL might have had on the process. This
increased the reliability and validity of the data collection.
Collection
All data were collected and organized by the PL. The surveys completed by team
members, both at the beginning of Phase 1 and at the completion of Phase 2, were anonymous.
Team members were instructed to place the completed survey in a locked box at the nurse’s
station, in the pediatric hematology/oncology outpatient clinic. Surveys were reviewed for
commonalities. Themes from Phase 1 surveys were presented, anonymously, in the
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PowerPoint®, during the team member meeting (see Appendix F). This was in an effort to
analyze the current Med Rec process and formulate an improved standardized process.
A portion of Phase 1 data, or pre-intervention data, was collected by the PL from the
patients EHR. All electronic data were accessed using a password protected account. The data
were coded to ensure patient privacy (see Appendix H). Coded data were kept separately from
data containing patient information, both in locked boxes.
In Phase 2, the data collection form completed by the team members was collected in a
locked box, located at the nurse’s station in the clinic (see Appendix I). The data collection
forms were collected, by the PL, from the box once a week. The forms were then placed in an
envelope for transport to a work station on the unit, in an effort to keep patient information
confidential. The forms were coded and patient labels were removed at this time (see Appendix
H). The coded data were kept separately from the code sheet, both in locked boxes. Similar to
Phase 1, the EHR was accessed to collect demographics and medication discrepancy data,
using a password protected account. Study data will be destroyed at the conclusion of the EBP
project and after dissemination of the project results.
Management and Analysis
Data collected during the project was analyzed by the PL using Statistical Package for
the Social Sciences (SPSS) 22, a computer program for statistical analysis. Phase 1 and 2 data,
specifically the number, type, and severity of the medication discrepancies, were compared
using descriptive statistics. The mean and standard deviation of the number of discrepancies
was examined. An update on the number, type, and severity of medication discrepancies was
sent to team members, via email. The overall trends in medication discrepancies were
analyzed. Retrospectively, the number of medication error reports was examined. The number
of reports during Phase 1 and 2 were compared, as well as examination of the medication error
reports, during the same time the previous year.
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Protection of Human Subjects
Prior to planning and implementing this EBP project, the PL completed a web based
ethics training, through the National Institute of Health (see Appendix J). This training certified
the PL to uphold ethical consideration, during the entirety of this EBP project. Approval from
both Valparaiso University’s and the agency’s IRB was received. Once approval was obtained,
the PL contacted the project site’s contact person and set up a calendar for project
implementation.
The surveys completed at the end of Phase 1 and 2 were anonymous, to protect team
member’s privacy. Completed surveys were placed in a locked box at the nurse’s station, prior
to collection. The Physician Medication Reconciliation Tracking Form and the Medication
Reconciliation Process Data Collection Form both included patient identification information at
the top (see Appendices C and I). These forms were completed by team members, and upon
completion, were placed in a locked box. The collected forms were collected and coded by the
PL. Once the forms were coded the patient identification information was removed from the
form, to protect patient information. Coded data were kept separate from the master code sheet,
both in locked boxes. All data collection materials will be destroyed after project conclusion and
results dissemination.
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CHAPTER 4
FINDINGS
The purpose of this EBP project was to improve the accuracy of the Med Rec process in
a pediatric hematology/oncology outpatient clinic by developing, promoting, and evaluating a
standardized, collaborative Med Rec process. A detailed literature search was conducted in an
effort to implement an evidence-based intervention that would improve outcomes. The clinical
question this EBP project addressed was: Will a standardized, collaborative Med Rec process
that is communicated to all team members and patients, decrease the number of medication
discrepancies? The evidence-based intervention included a patient/caregiver component and a
team member component. The outcomes measured during Phase 1 and 2 included the number,
type, and severity of medication discrepancies and the number of medication errors reported via
a voluntary computer system. Also, a survey assessing the climate of the Med Rec process was
completed by team members and collected by the PL during Phase 1 and 2. Data were
collected during Phase 2 that assessed the implemented Med Rec process compliance.
Participant characteristics and descriptive statistics were calculated using SPSS 22.
Participants
The participant analysis is comprised of the team members who completed the Phase 1
and 2 survey and patients seen in the clinic during Phase 1 and 2. During both Phase 1 and 2,
the number of visits, or number of Med Rec process completions, was recorded because one
patient could have presented for numerous visits. The number of medications the patient was
taking including OTC, herbal supplements, vitamins, and prescriptions was recorded for each
visit as well. The sample size and characteristics will be further discussed at this time.
Size
Demographic data were collected on team members who completed a survey, both prior
to the completion of Phase 1 and 2. A total of nine team members completed the survey at the
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conclusion of Phase 1 and a total of five team members completed the survey at the conclusion
of Phase 2. Demographic survey data collected included age, gender, ethnicity, highest level of
education, current employment status, current position, and length of employment in the project
setting. Med Rec accuracy information was collected during Phase 1 and 2 by both the
physicians and PL. Demographic data were collected by the PL on patients during Phase 1 (n =
78) and Phase 2 (n = 94). There were 172 patient participants in this EBP project. Patient
demographic data collected included age, gender, and diagnosis. Diagnosis was divided into
two categories, oncology related or hematology related. During the duration of the project, both
Phase 1 and 2, there were 229 visits in which the Med Rec process was completed and
reviewed by the physician. Phase 1 included 99 visits and Phase 2 included 130 visits. Half of
the visits during Phase 1 (n = 50) and Phase 2 (n = 65) were randomly selected by the PL for
PL Med Rec accuracy data collection.
Characteristics
Team members. The average age of team members during Phase 1 was 49.4 years
(SD = 10.4) with a range of 33-63 years. All team members that completed the Phase 1 survey
were female and Caucasian. Two team members (22.2%) reported their highest level of
education being some college, three (33.3%) reported having an associate’s degree, three
(33.3%) reported having a bachelor’s degree, and one (11.1%) participant reported having a
medical degree. Employment status varied from full-time (n = 7, 77.8%), part-time (n = 1,
11.1%), to as needed (n = 1, 11.1%). One physician (11.1%), six nurses (66.7%), and two unit
assistants (22.2%) completed the Phase 1 survey. The average length of team member
employment at the clinical site was 12.2 years (SD = 10.0) with a range of 1.5-24 years.
The average age of team members during Phase 2 was 53.4 years (SD = 11.9), with a
range of 33-63 years. All team members that completed the Phase 2 survey were female and
Caucasian. Highest level of education included: one team member (20%) reported some
college, three (60%) reported having an associate’s degree, and one (20%) reported having a

MEDICATION RECONCILIATION

63

bachelor’s degree. All team members who completed the Phase 2 survey reported working fulltime. Four nurses (80%) and one unit assistant (20%) completed the Phase 2 survey. The
average team member length of employment at the clinical site was 16.9 years (SD = 10.5) with
a range of 1.5-24 years.
There was no significant difference in team member age between Phase 1 and 2 (t(14) =
-.644, df = 11, p = .533). There was no significant difference in team member’s highest level of
education between Phase 1 and 2 (X2 = 1.296, df = 3, p = .730). There was no significant
difference in team member’s employment status between Phase 1 and 2 (X2 = 1.296, df = 2, p =
.523). There was no significant difference in employee’s position between Phase 1 and 2 (X2 =
0.643, df = 3, p = .725). There was no significant difference in team members age between
Phase 1 and 2 (t(14)= -.772, df = 11, p = .456).
Patients. In Phase 1, the average age of patients (n = 78) was 9.4 years (SD = 6.0). In
Phase 1, 32 (41%) patients were female and 46 (59%) were male. Fifty patients (64.1%) had
oncology related diagnoses and 28 patients (35.9%) had hematology related diagnoses.
In Phase 2 the average age of patients (n = 94) was 9.6 years (SD = 6.2). In Phase 2, 39
(41.5%) patients were female and 55 (58.5%) were male. Sixty two patients (66%) had oncology
related diagnoses and 32 patients (34%) had hematology related diagnoses.
There was no significant difference in age between Phase 1 and 2 patients (t(172) = .220, df = 170, p = .826). There was no significant difference in gender between Phase 1 and 2
patients (X2 = .004, df = 1, p = .951). There was no significant difference in diagnosis between
Phase 1 and 2 patients (X2 = .065, df = 1, p = .799).
Visits. The average number of medications reconciled per visit during Phase 1 (n = 99)
was 4.9 medications (SD = 3.6), with a range of 0-13 medications. The average number of
medications reconciled per visit during Phase 2 (n = 130) was 4.8 medications (SD = 3.8), with
a range of 0-14 medications. There was no significant difference in the number of medications
reconciled during Phase 1 and 2 patient visits (t(229) = .163, df = 227, p = .871).
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When considering only the patient visits reviewed by both the physician and the PL, the
average number of medications reconciled per visit during Phase 1 (n = 50) was 5.1
medications (SD = 3.7), with a range of 1-13 medications. The average number of medications
reconciled per visit during Phase 2 (n = 65) was 4.8 medications (SD = 3.8), with a range of 014 medications. There was no significant difference in the number of medications reconciled
during Phase 1 and Phase 2 patient visits (t(115) = .431, df = 113, p = .680).
Changes in Outcomes
Reliability
For this EBP project, the PL created the data collection tools. The data collection tools
included the Phase 1 and 2 team member survey, the Med Rec tracking forms, and the Med
Rec process data collection form. Internal consistency testing, using Cronbach alpha, was not
appropriate, although steps were taken to ensure reliability. The data collected was nominal and
single items were used to measure distinct concepts. The team members responsible for data
collection were educated on proper data recording technique. In an effort to ensure reliability,
the physician’s and PL used the same data collection forms during Phase 1 and Phase 2 and
used the same recording process during each phase.
Statistical Testing and Significance
Primary outcomes. Primary outcomes of this EBP project include the number, type,
and severity of medication discrepancies. Medication discrepancies were defined using the
terms completeness, correctness, and accuracy found in the literature (Nassaralla et al., 2007;
Nassaralla et al., 2009). A medication list was considered complete when each medication had
a name, dose, frequency, and route of administration documented in the EHR. A medication list
was considered correct if there were no discrepancies between the medication list in the EHR
and what medications the patient was taking at home. Med Rec accuracy was defined as a
medication list being both complete and correct. When a medication discrepancy was found its
severity was classified. The severity of the discrepancies were classified using the class 1, 2,
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and 3 scale (Huynh et al., 2013; Huynh et al., 2016). Class 1 was assigned to medication
discrepancies that were potentially minor. Class 2 was assigned to medication discrepancies
that were potentially moderate. Class 3 was assigned to medication discrepancies that were
potentially severe. Medication discrepancy data was collected by both the physician and the PL.
Also, the number of voluntarily reported medication errors was assessed during the duration of
the project and the same time frame the previous year.
Med Rec Discrepancies. The physicians collected Med Rec data on 229 patient visits,
Phase 1 (n = 99) and 2 (n = 130). The PL then randomly selected half of the patients to verify
Med Rec data on. An attempt was made to contact the randomly selected patients/caregivers
via telephone to verify the correctness of the medication list documented in the EHR. During
Phase 1, the PL attempted to complete correctness data on 50 patient visits. The Med Rec
correctness was verified for 26 of the 50 patient visits (52%). In Phase 2, the PL attempted to
complete correctness data on 65 patient visits. The Med Rec correctness was verified for 40 of
the 65 patient visits (61.5%). There was no significant difference in the Med Rec correctness
verification by the PL between Phase 1 and 2 (X2 = 1.051, df = 1, p = .305). There were three
reasons correctness was not verified: the caregiver did not answer the telephone call, the
caregiver refused to verify the patient’s medications with the PL, or the patient was admitted to
the hospital. Figure 4.1 provides participant and non-participant information, specifically
correctness verification information.
Accuracy. Accuracy data included whether the Med Rec was complete and correct. In
Phase 1 the physician collected these data on 99 patient visits. The physician’s collected data
from only the EHR. The Med Rec was recorded as accurate in 79 of the 99 (79.8%) patient
visits. During Phase 2, Med Rec was recorded as accurate in 115 of the 130 (88.5%) patient
visits. A chi-square test of independence was calculated comparing the results of all of the
physician reported Med Rec accuracy during Phase 1 (n = 99) and 2 (n = 130). While the
accuracy rate improved, no significant relationship was found (X2 = 3.258, df = 1, p = .071).
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Figure 4.1 Phase 1 and Phase 2 Participant and Non-Participant Flow Chart

Total Participants
Phase 1: n = 99
Phase 2: n = 130

Randomly Selected
Participants
Phase 1: n = 50 (50%)
Phase 2: n = 65 (50%)

Correctness Participants
Phase 1: n = 26 (52%)
Phase 2: n = 40 (61.5%)

Unreachable
Phase 1: n = 19 (79.2%)
Phase 2: n = 23 (92%)

Non-participants
Phase 1: n = 24 (48%)
Phase 2: n = 25 (38.5%)

Refused
Phase 1: n = 3 (12.5%)
Phase 2: n = 2 (8%)

Admitted
Phase 1: n = 2 (8.3%)
Phase 2: n = 0 (0%)

_________________

The PL randomly selected half of the patient visits that the physicians collected accuracy
data for Phase 1 and 2. The PL data were collected from both the EHR and the caregiver (via
telephone call). During Phase 1, 19 (73.1%) of the 26 verified Med Recs were found to be
accurate. In Phase 2, 29 (72.5 %) of the 40 verified Med Reds were found to be accurate.
Overall, there was a slight decrease in the percentage of accurate Med Recs from Phase 1 to
Phase 2 from 73.1% to 72.5%. A chi-square test of independence was calculated comparing the
results of the PL reported Med Rec accuracy during Phase 1 and 2. No significant relationship
was found (X2 = .003, df = 1, p = .959).

MEDICATION RECONCILIATION

67

When examining the patient visits in which the physician and PL both collected data,
Phase 1 (n = 50) and Phase 2 (n = 65), there was a significant decrease in the number of
inaccurate Med Recs recorded by the physicians (X2 = 8.167, df = 1, p = .004). In Phase 1, 35
of 50 (70%) Med Recs were reported accurate and in Phase 2 59 of 65 (90.8%) were reported
as accurate by the physicians (Figure 4.2).
Figure 4.2 Inaccurate Med Recs

Percentage of Inaccurate Med Recs
Percentange of Inaccurate Med Recs

35
30
30

26.9

27.5

25
20.2
20
15

11.5
9.2

10
5
0
Total Physician Inaccuracy

Matched Physician Inaccuracy
Phase 1

PL Inaccuracy

Phase 2

Inaccuracy. The reason for Med Rec inaccuracy was recorded by both the physician
and the PL. The Med Rec was considered inaccurate because it was incomplete, incorrect, or
both. Incompleteness was defined as at least one medication missing the name, dose,
frequency, or route of administration in the EHR. Incorrectness occurred when a discrepancy
existed between the patient’s medication list in EHR and what medication(s) the patient was
taking at home. In Phase 1 (n = 99) the physicians recorded, three (15%) of the 20 inaccurate
Med Recs were incomplete, 16 (80%) were incorrect, and one (5%) was both incomplete and
incorrect. In Phase 2 (n = 130), two (13.3%) of the 15 inaccurate Med Recs were recorded as
incomplete, 13 (86.7%) were recorded as incorrect, and none were recorded as both incomplete
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and incorrect. There was no significant difference between the physician reported Med Rec
inaccuracy reason between Phase 1 and 2 (X2 = .813, df = 2, p = .666).
In Phase 1 (n = 50) the PL recorded, five (71.4%) of the seven inaccurate Med Recs
were incomplete, one (14.3%) was incorrect, and one (14.3%) was both incomplete and
incorrect. In Phase 2 (n = 65), nine (81.8%) of the 11 inaccurate Med Recs were recorded as
incomplete, two (18.2%) were recorded as incorrect, and none were recorded as both
incomplete and incorrect. There was no significant difference between the PL reported Med Rec
inaccuracy reason between Phase 1 and 2 (X2 = 1.670, df = 2, p = .434).
When examining inaccurate Med Recs in which the physician and PL both collected
data, in Phase 1 (n = 50) the physicians recorded, three (20%) of the 15 inaccurate Med Recs
were incomplete, 11 (73.3%) were incorrect, and one (6.7%) was both incomplete and incorrect.
In Phase 2 (n = 65), one (16.7%) of the six inaccurate Med Recs were recorded as incomplete,
five (83.3%) were recorded as incorrect, and none were recorded as both incomplete and
incorrect. There was no significant difference between the physician reported Med Rec
inaccuracy reason between Phase 1 and 2 (X2 = .481, df = 1, p = .786).
Incompleteness. The reason for incomplete Med Recs was further delineated into what
element of the medication was missing, specifically the name, dose, frequency, route of
administration, or a combination (see Table 4.1). The incomplete combination noted in Phase 1
was missing frequency and route. There was a significant difference between physician
incompleteness data between Phase 1 and 2 (X2 = 6.000, df = 2, p = .050). The PL incomplete
combinations in Phase 1 were two missing route and frequency, two missing dose and
frequency, and one missing dose, frequency, and route. There was no significant difference
between PL incompleteness data between Phase 1 and 2 (X2 = 5.278, df = 4, p = .260). When
examining inaccurate Med Recs in which the physician and PL both collected data, there was
no significant difference between physician incompleteness data between Phase 1 and 2 (X2 =
5.000, df = 2, p = .082).
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Table 4.1
Incompleteness Data for Phase 1 and Phase 2
Total
Physician
Phase 1
(n = 99)
4

Total
Physician
Phase 2
(n = 130)
2

Matched
Physician
Phase 1
(n = 50)
4

Matched
Physician
Phase 2
(n = 65)
1

PL
Phase 1
(n = 50)

PL
Phase 2
(n = 65)

6

9

Name

-

-

-

-

-

-

Dose

-

2 (100)

-

1 (100)

2 (33.3)

2 (22.2)

3 (75)

-

3 (75)

-

4 (66.7)

2 (22.2)

-

-

-

-

-

Total
Incomplete
Reason (# (%))

Frequency
Route

-

Combination
1 (25)
1 (25)
5 (55.6)
Note. Combination includes medications missing more than one component, for example both
dose and frequency missing.
Incorrectness. The reason for incorrect Med Recs were further delineated into what
element of the EHR did not match what the patient was taking at home. Incorrectness options
included addition, omission, duplication, incorrect name, incorrect dose, incorrect frequency,
incorrect route of administration, or a combination (see Table 4.2). The incorrect combinations
in Phase 1 included a medication list with an addition and an incorrect name documented.
Phase 2 incorrectness combinations included a medication list with and addition and incorrect
dose. There was no significant difference between physician incorrectness data between Phase
1 and 2 (X2 = 7.014, df = 5, p = .220).
The PL recorded incorrectness combination in Phase 1 was a medication list that
included an addition, omission, and incorrect dose. There was no significant difference between
PL incorrectness data between Phase 1 and 2 (X2 = 2.000, df = 2, p = .368).
When examining inaccurate Med Recs in which the physician and PL both collected
data, in Phase 1 the incorrect combination was the result of an addition and incorrect name.
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There was no significant difference between physician incorrectness data between Phase 1 and
2 (X2 = 1.747, df = 4, p = .782).
Table 4.2
Incorrectness Data for Phase 1 and Phase 2
Total
Physician
Phase 1
(n = 99)
17

Total
Physician
Phase 2
(n = 130)
13

Matched
Physician
Phase 1
(n = 50)
12

Matched
Physician
Phase 2
(n = 65)
5

PL
Phase 1
(n = 50)

PL
Phase 2
(n = 65)

2

2

Addition

3 (17.6)

2 (15.4)

1 (8.3)

1 (20)

-

-

Omission

8 (47.1)

10 (76.9)

8 (66.7)

4 (80)

-

-

Duplication

-

-

-

-

-

Incorrect name

-

-

-

-

-

Incorrect dose

3 (17.6)

-

1 (8.3)

-

2 (50)

Incorrect
frequency

2 (11.8)

-

1 (8.3)

-

-

-

-

-

-

Total Incorrect
Reason (# (%))

Incorrect route

-

1 (50)
1 (50)

-

Combination
1 (5.9)
1 (7.7)
1 (8.3)
1 (50)
Note. Combination includes and EHR medication list with one than one component not
matching what the patient is taking at home, for example a patient with an omitted medication
and a medication with an incorrect dose documented.
Severity. When the physicians or PL recorded a Med Rec as inaccurate, a severity was
assigned. Class 1 was assigned to medication discrepancies deemed potentially minor. Class 2
was assigned to medication discrepancies deemed potentially moderate. Class 3 was assigned
to medication discrepancies deemed potentially severe. Figure 4.3 details total and matched
physician and PL severity ratings for Phase 1 and 2. No inaccurate Med Recs were classified by
the physicians or PL as severe in Phase 1 or 2. There was no significant difference in total
physician Med Rec inaccuracy severity between Phase 1 and 2 (X2 = .034, df = 1, p = .854).
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There was no significant difference in PL Med Rec inaccuracy severity between Phase 1 and 2
(X2 = 1.039, df = 1, p = .308). When examining the matched physician inaccurate Med Rec
severities there was no significant difference in Med Rec inaccuracy severity between Phase 1
and 2 (X2 = .827, df = 1, p = .363).
Figure 4.3 Inaccurate Med Rec Severity Ratings

Inaccurate Med Rec Severity
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Note: No inaccurate Med Recs were given a class 3- severe rating by the physicians or PL.
Reported Medication Errors. There were no voluntary reported medication errors
during the duration of this EBP project. There were no voluntary reported medication errors
reported during the same time frame the previous year.
Secondary outcomes. Secondary outcomes of this EBP project included data collected
by the team members regarding the compliance to the Med Rec process during Phase 2 and
team member survey results prior to the end of Phase 1 and 2. The Med Rec process data
collected included if the caregiver was reminded to bring the patients medication to the next
visit, if the caregiver brought their child’s medications to the appointment, if the patient and
caregiver were educated regarding the Med Rec process during the visit, if so by who (role),
and if all three steps of the Med Rec process were completed (verification, clarification, and
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reconciliation) and by who (role). Patient/caregiver education role options included the MA,
nurse, or both the MA and the nurse. The Med Rec step completion role options included the
MA, nurse, both the MA and the nurse, or the physician. Med Rec process data were collected
on 111 (85%) of the 130 Phase 2 patient visits.
Medication reminder. The caregiver was reminded to bring their child’s medications to
their child’s next visit prior to 91.9% (102 out of 111) of the patient visits during Phase 2. The
main reason cited for not reminding caregivers to bring their child’s medications to the visit was
lack of voicemail to leave a message or incorrect/disconnected phone number provided by
caregiver (no statistical data available regarding reasons medication reminder did not occur).
Medications to appointment. Of the 130 patient visits in Phase 2, 106 had data
recorded regarding whether the caregiver brought their child’s medications. For 55 (51.9%) of
the patient visits, caregivers brought the child’s medication(s) to the appointment. For 32
(30.2%) of the patient visits, caregivers did not bring their child’s medication(s) to the
appointment. For 19 (17.9%) of the patients visits, children were recorded as not taking any
medications, therefore none were brought to the appointment.
Patient education. First the team members indicated whether the patient/caregiver was
educated. If the patient/caregiver was educated, the role of the educator was selected and could
include MA, nurse, or both MA and the nurse. Already educated was also an option for the
same patients with multiple visits. The team members recorded patient education data on 110 of
the 130 patient visits in Phase 2. Sixty-eight (61.6%) of patients/caregivers were educated by
the MA, 17 (15.5%) were educated by the nurse, and five (4.5%) were educated by both the MA
and nurse. Twenty patients/caregivers (18.2%) were repeat patients and did not receive
education the second time they presented for a visit.
Med Rec process. The Med Rec process section of the team member data form
detailed if the steps of the Med Rec process (verification, clarification, and reconciliation) were
completed and by who. Verification and clarification role completion options included MA, nurse,
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or both the MA and nurse. The only reconciliation role option included was physician, as the
physician was the only person responsible for the completion of the Med Rec process. Sixty-five
percent (58 out of 89) of Med Rec verification was completed by the MA, 20% (18 out of 89)
was completed by the nurse, and 15% (13 out of 89) was completed by both the MA and the
nurse. Fifty-nine percent (51 out of 87) of Med Rec clarification was reported as completed by
the MA, 28% (24 out of 87) was completed by the nurse, and 14% (12 out of 87) of the
clarification was completed by both the MA and the nurse. One hundred percent (87 out of 87)
Med Recs were reconciled by a physician.
Team member survey. The demographics collected from the team member survey
were previously discussed. Common themes were present when the PL reviewed the openended questions of the survey. At the conclusion of Phase 1, when asked what aspects of the
Med Rec process were working well, team members commonly identified the use of the EHR,
especially for repeat patients, as a tool in reducing time. When asked what aspects of the Med
Rec process were not working well team members commonly discussed patients not bringing
their medications to their visits and team members not thoroughly reviewing the medication list
upon patient arrival. Future ideas for improvement commonly included reviewing medications in
detail with all patients and nurses completing the Med Rec process with the help of the
physician.
Phase 2 survey results also found common themes. All participants reported that the
caregivers should continue to be reminded to bring their medications to their next visit,
patients/caregivers should continue to be educated regarding Med Rec, and that the Med Rec
process and discrepancies should continue to be tracked.
Significance
There were no significant differences in patient age, gender, or diagnosis between
Phase 1 (n = 50) and 2 (n = 65) (p < .799). No significant difference in the number of
medications per visit between Phase 1 and 2 (t(229) = .163, df = 227, p = .871) was found. The
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physician data for all patient visits reported an improvement in the Med Rec accuracy (X2 =
3.258, df = 1, p = .071). Also, the matched physician patient visits exhibited a significant
improvement in the number of inaccurate Med Recs between Phase 1 and 2 (X2 = 8.167, df = 1,
p = .004). There was a slight increase in the number of inaccurate Med Recs the PL recorded
between Phase 1 (26.9%) and 2 (27.5%) (X2 = .003, df = 1, p = .959). Physicians more
commonly reported Med Recs were inaccurate related to incorrectness, whereas the PL
reported more Med Recs were inaccurate related to incompleteness.
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CHAPTER 5
DISCUSSION
This EBP project explored the clinical question: Will a standardized, collaborative Med
Rec process that is communicated to all team members and patients, decrease the number of
medication discrepancies? The PICOT question developed was: In the pediatric
hematology/oncology outpatient population, how will the implementation of a standardized,
collaborative Med Rec process affect the number of medication discrepancies over the course
of two months, when compared to the current Med Rec practice? The goal of this EBP project
was to reduce the number of medication discrepancies and improve the current Med Rec
process using current evidence found in the literature. The outcomes measured included the
number, type, and severity of medication discrepancies and the number of medication errors
reported via a voluntary computer system. Also, a survey assessing the climate of the Med Rec
process was completed and Med Rec process compliance was tracked. This chapter discusses
the EBP project findings, applicability of the theoretical and EBP frameworks, strengths and
limitations of the project, and implications for the future.
Explanation of Findings
Primary outcomes of this EBP project included the number, type, and severity of
medication discrepancies. Also, the number of voluntarily reported medication errors was
assessed during the duration of the project and the same time frame the previous year.
Secondary outcomes of this EBP project included data collected by the team members
regarding compliance to the Med Rec process during Phase 2, and team member survey results
prior to the end of Phase 1 and 2.
Primary Outcomes
The accuracy of the Med Rec process during both Phase 1 and 2 was compared using
chi-square testing. When considering the overall physician Med Rec accuracy during Phase 1
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and 2, there was an increase in the number of accurate Med Recs, although not significant (X2 =
3.258, df = 1, p = .071). When considering the matched physician Med Rec accuracy data
during Phase 1 and 2, there was a significant increase in the number of accurate Med Recs (X2
= 8.167, df = 1, p = .004). The PL randomly selected half of the patient visits in which Med Rec
accuracy, specifically the correctness, was verified. Overall, there was a slight decrease in the
percentage of accurate Med Recs from Phase 1 to 2 and no significant relationship was found
(X2 = .003, df = 1, p = .959). The PL was the only person responsible for completing the Med
Rec accuracy data collection, in which the patient was called to verify data. Multiple physicians
were responsible for Med Rec accuracy data, using the EHR and their personal knowledge of
the patient’s plan of care.
The physicians and PL considered the Med Rec inaccurate if it was incomplete,
incorrect, or both. The physicians found a larger number of inaccurate Med Recs related to
incorrectness, whereas the PL found a larger number of inaccurate Med Recs related to
incompleteness. There was no significant difference between the physician or PL Med Rec
inaccuracy reason between Phase 1 and 2 (p = .434). One explanation for the difference in
correctness between the physician and PL’s accuracy is that the physicians may have reviewed
the Med Rec, found the incorrectness, fixed the discrepancy, and then the PL verified the
correct EHR list with the patient. Also, the PL may have completed a more detailed review of
each component of the medication, specifically looking for documentation of each medications
name, dose, frequency, and route of administration.
Regardless of the Med Rec reviewer, the most commonly missed component of the
medication documentation, causing inaccuracy, was a medication missing the frequency or
dose. An example of an incomplete medication documentation related to missing frequency was
Tylenol 650 mg PO prn pain. Another example of an incomplete medication documentation
related to missing dose was Tylenol PO Q6H prn pain. Both examples represent an inaccurate
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Med Rec. The PL found Med Recs that were recorded as accurate by physicians that were in
fact not accurate as a result of incompleteness.
The most commonly recorded incorrectness reason by the physicians was omission. It is
interesting to note that the PL did not record any instances where the Med Rec was inaccurate
related to a medication omission. Perhaps this could be attributed to the fact that the physicians
are developing and implementing the plan of care. They could be considered the most
knowledgeable person when it comes to knowing what medications the patient is currently
taking.
When the physicians or PL recorded a Med Rec as inaccurate, a severity was assigned.
Regardless of the reviewer, the most commonly assigned severity was class 1, or minor,
followed by class 2, or moderate. No inaccurate Med Recs were classified by the physicians or
PL as severe in Phase 1 or 2. The severity rating was subjective and offered insight into the
possible ramifications of the inaccurate Med Rec.
There were no voluntary reported medication errors during the duration of this EBP
project. There were no voluntary reported medication errors reported during the same time
frame the previous year. The team members were encouraged during the education component
of the intervention to complete medication error reports when Med Recs were inaccurate and
patient safety was compromised.
Secondary Outcomes
Secondary outcomes of this EBP project included data collected by the team members
regarding compliance to the Med Rec process during Phase 2 and team member survey results
prior to the end of Phase 1 and 2. In regards to the Phase 2 Med Rec Process data collection,
the caregiver was reminded to bring their child’s medications to the next visit prior to 91.9% of
the patient visits. In Phase 2, the large percentage of completed patient/caregiver reminders
may be due to the fact that the clinic had a system in place, prior to the implementation of this
project, in which the caregivers were called and reminded of their child’s appointment. The
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caregiver reminder to bring their child’s medications was not considered a time consuming task
by many team members. Also, the unit assistants responsible for the reminder calls were
receptive to improving the patient’s safety and encouraging caregiver involvement in the Med
Rec process. The reasons cited for not reminding caregivers to bring their child’s medications to
the visit, lack of voicemail to leave a message or incorrect/disconnected phone number provided
by caregiver, were not something that could be controlled by team members in the clinic.
Despite the large number of caregivers reminded to bring their child’s medications to the visit, a
large percentage did not bring their child’s medications. Perhaps this is related to the frequency
in which pediatric hematology/oncology patients are visiting the outpatient clinic. However,
these data provide additional support to augment the process of reminding caregivers to bring
medications to each child’s visit.
Overall, team members did an excellent job of educating the caregivers and patients,
using the handout for Med Rec. All the patients with Med Rec process data collected were
educated if it was their first visit. The majority of the education was performed by the MA. During
the duration of the project, the MA was responsible for checking the patient in and performing
the first two steps of the Med Rec process. This could be the reason why the patient/caregiver
was most commonly educated by the MA. This could also be the reason that the first two steps
of the Med Rec process were most commonly completed by the MA. The final Med Rec process
step, reconciliation, was recorded as 100% completed by the physicians. It is important to
mention that, after the project was completed, the Med Rec process changed and now the
nurse is responsible for the Med Rec verification and clarification steps of the process. This
change was in an effort further improve Med Rec accuracy and ensure that adequately trained
team members were completing the Med Rec process. In this setting, the nurses have
specialized training and certification in pediatric hematology/oncology care.
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Relationship to the Current Literature
This EBP project confirmed literature findings that it is challenging to improve medication
safety in pediatrics, using the Med Rec tool (Huynh et al., 2013). In this EBP project setting, the
Med Rec inaccuracy rate reported by the physicians in Phase 1 was 20.2% and in Phase 2 the
Med Rec inaccuracy rate reported by the physicians was 11.5%. Huynh et al. (2016) cited that
58% of prescriptions contained a medication discrepancy. However, the Huynh et al. (2016)
study was conducted in the pediatric inpatient setting and medication discrepancy was defined
as a difference in the pre admission medication list and admission medication orders. This
definition was not applicable to the pediatric outpatient setting in this project.
Nassaralla et al. (2007) found improvement in correctness between pre- and postintervention was not significant (23.7% to 18%). Nassaralla et al. (2009) found that the overall
number of complete medication lists improved between pre-intervention, LPN-intervention, and
patient intervention phases. Also, the overall accuracy improved from pre-intervention (11.5%)
to patient intervention (29%) (Nassaralla et al., 2009). These overall accuracy numbers, whether
pre-intervention or post-intervention are lower than reported in this EBP project (Phase 1: 79.8%
total physician accurate Med Recs and Phase 2: 88.5% total physician accurate Med Recs). In
addition, Varkey et al. (2007) reported higher medication discrepancy numbers than reported in
this project (Phase I: 98.2% Med Rec with a discrepancy and Phase II: 84% Med Recs with a
discrepancy). When comparing the literature with the project site, there appears to be far less of
a problem with inaccurate Med Recs. However, given the vulnerability of the patient population
at the project site, Med Rec accuracy and patient safety can certainly be improved.
Varkey et al. (2007) found that incorrect or missing route was the most common
medication discrepancy. This discrepancy is in contrast to this EBP project which found
frequency to be the most commonly undocumented component of the Med Rec. Nassaralla et
al. (2007) showed improvement in completeness, specifically the documentation of dose and
route, between their pre-intervention, post-intervention, and sustainability phases. Again this is
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in contrast to this project finding of missing frequency as the most common incompleteness
reason.
With regards to severity ratings, the physicians and PL reported no Med Rec
inaccuracies as severe. This finding is in contrast to Huynh et al. (2016), in which the same
classification system was used, when 22% of medication discrepancies were found to be class
1 (minor), 50% were found to be class 2 (moderate), and 28% were found to be class 3
(severe). The severity results of this project are similar to Hron et al. (2015) in which no major or
catastrophic ADE’s were found pre-intervention or post- intervention. Finally, according to
Varkey et al. (2007), the most commonly recorded severity was minor, 0.3% of medication
discrepancies were serious and no lethal medication discrepancies were recorded.
When examining the percentage of visits in which medications were brought from home,
a rate of 51.9% during Phase 2 of this project is more than the reported rate of 38.5% by Huynh
et al. (2016) and the 13.9% pre-intervention and 33% post-intervention reported by Nassaralla
et al. (2009). When compared with this project, Varkey et al. (2007) reported a similar number of
visits with medications present in Phase II (52%).
Correctness during Phase 1 (52%) and Phase 2 (61.5%) of this EBP project was similar
to what Nassaralla et al. (2007) reported, pre-intervention (69%) and post-intervention (61%).
Also, Nassaralla et al. (2009) reported correctness participation similar to this EBP project, preintervention (56%), LPN intervention (51%), and patient intervention (60%).
None of the literature used to formulate the intervention or data collection tools used a
Med Rec process compliance tracking tool. The Med Rec process tracking tool was extremely
helpful in this specific project setting. It served as a reminder to team members and increased
individual accountability.
Unexpected Findings
It was not anticipated that there would be a difference in the physician and PL reported
number of accurate Med Recs. It was also not expected that there would be a slight increase in
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the number of PL recorded inaccurate Med Recs between Phase 1 and Phase 2. The
physicians found and corrected mostly incorrectness errors prior to the PL verifying the
correctness. However, the physicians in both Phase 1 and Phase 2 did not find and report the
incompleteness errors that the PL found. This could be related to the fact that the physicians are
proficient and knowledgeable regarding the patient medication regimens, increasing the
likelihood of finding incorrectness errors; however, the physicians could benefit from
improvement in monitoring for incompleteness errors. The most frequently cited reasons for
inaccuracies, specifically missing frequency for incompleteness and omission for incorrectness,
were not expected based on the existing literature. The team member survey results prior to the
conclusion of Phase 2 were surprising in that all participants expressed that the standardized,
collaborative Med Rec process and tracking should continue. Finally, it was discovered that
medication error reports are not commonly completed in this setting. This fact limited the ability
to examine the effect of the implemented Med Rec process on patient safety.
Evaluation of Applicability of Theoretical and EBP Frameworks
The theoretical framework that was used to guide this EBP project was Kotter’s Model of
Change. In addition to Kotter’s Model of Change, the Stetler EBP Model was used to guide the
implementation of best practice in the clinical setting. The theoretical framework and EBP
framework appropriateness, strengths, and limitations are discussed further.
Theoretical Framework
Kotter’s Model of Change laid a foundation to successfully implement this EBP project
and change current practice. The eight stages of Kotter’s Model of Change are: (1) establish a
sense of urgency, (2) create a powerful guiding coalition, (3) develop a vision, (4) communicate
the vision, (5) empower others to act on the vision, (6) plan for and create short-term wins, (7)
consolidate improvements and produce more change, and (8) institutionalize new approaches
(Ritter, 2011). Each stage of the model was used to overcome barriers to change in the project
setting.
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Theoretical Framework Appropriateness. Kotter’s Model of Change was a good fit for
the project, as it was detailed in its discussion of empowering team members to change current
practice. This task was especially difficult in the project setting. The model set up an
environment in which change was openly discussed and agreed upon. The baseline data
collected were helpful in creating a sense of urgency and facilitating the realization of the clinical
problem.
Strengths of Theoretical Framework. Kotter’s Model of Change was useful when
implementing this organizational change. Kotter’s Model of Change was easy to follow and
simplistic, yet it was also thorough when it came to the entirety of the change process. The
additional detail and steps that Kotter’s Model of Change offered, in comparison to Lewin’s
Model of Change, was helpful to the novice PL. Also, the thoroughness was appreciated in a
climate, such as the project site, where change was resisted and difficult to implement.
Limitations of Theoretical Framework. Kotter’s Model of Change contains eight
stages, which at times proved to be laborious and overwhelming to the novice PL. The model
was described in a linear, step-by-step approach, which was more simplistic than change in the
real environment. Changing the Med Rec process was complex and affected by many
conditions. Unfortunately, the PL was seen by team members as the facilitator of the change
and a powerful guiding coalition was not adequately formed. The lack of a powerful coalition set
the change up to be resisted and not further continued after project completion.
EBP Framework
The Stetler Model of Evidence Based Practice was ideal in guiding the implementation of
this EBP project. The Stetler EBP Model has five phases: (1) preparation, (2) validation, (3)
comparative evaluation/decision making, (4) translation/application, and (5) evaluation (Dang et
al., 2015 & Young, 2015). In the first phase, preparation, a problem is identified; the context of
the problem is reviewed; and searching for evidence occurs. In the validation phase, the body of
evidence is systematically searched. The second stage also includes choosing and
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summarizing the evidence. The third phase involves organizing and condensing the evidence.
The fourth phase involves the actual change in practice, or translation/application. The evidence
is converted into the recommended intervention of change. The application is planned and the
implementation strategy is put into action. Evaluation is the fifth, and final stage, of the Stetler
Model. The evaluation stage involves evaluating the plan and determining if the goals were met
(Dang et al., 2015 & Young, 2015).
EBP Framework Appropriateness. The Stetler EBP Model was appropriate and
extremely applicable to this EBP project. The model detailed the process of successfully
implementing evidence into practice. The model re-enforced using literature in clinical practice
to improve a clinical problem.
Strengths of EBP Framework. Strengths of the Stetler EBP Model included an easy to
follow step-by-step approach to implementing evidence into practice. The step-by-step
approach was extremely helpful to the novice PL. Although the patient population and setting
was specific, the Stetler EBP Model was easily applied. The visual flowchart and graph that
detailed the steps of EBP implementation were helpful. The steps laid the foundation for
successful EBP implementation. The foundation and focus of the Stetler EBP Model is critical
thinking and using research findings to guide care, which was the ultimate goal of this EBP
project.
Limitations of EBP Framework. The Stetler EBP Model’s limitations include the
number of steps and also the complexity of each step. The steps at times seemed
overwhelming and lengthy. Finally, the model flows in a linear pattern, and as discussed with
the Kotter’s Model of Change, EBP implementation is complex.
Implementation Modifications
The implementation of the EBP project was fully supported by the site contact and the
medical director of the clinic. One meeting was set up with the medical director to review the
project, proposed data collection/outcomes, and the intervention. The medical director desired
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to educate the other physicians on the project, data collection requirements, and intervention.
Also, the timeframe was adjusted, the medical director was willing to collect data for three
weeks pre-intervention and three weeks post-intervention, on every patient.
During Phase 1 data collection, team members became suspicious of the physician data
collection and began asking the PL questions. It was imperative not to discuss the details of
data being collected, in an effort to ensure behaviors did not change based on process
monitoring. There is a chance that the team members discovered the Med Rec process was
being tracked and sought to improve accuracy prior to the intervention.
The PL developed a script used during correctness data collection to ensure consistent
representation of the project and data collection. Also, during Phase 1 the PL had to inform the
charge nurse of the project and data collection. This was in an effort to provide competent
ethical care to the patients whose Med Rec needed clarification or additional follow up.
The team members were receptive during the education component of the intervention.
Role responsibility in the Med Rec process was clearly defined and agreed upon at this time.
Once the team member data collection began, the team members often discussed the
additional time the data collection form required. The PL was available during Phase 2 to
reassure and encourage team members of the importance of accurate Med Rec. There were no
physician’s present during the unit meeting when the Med Rec education was provided by the
PL.
Future Modifications
In the future if this project were to be re-implemented, there are modifications that may
be beneficial. Prior to implementation of future Med Rec focused EBP projects a specific
process to manage Med Rec inaccuracies found should be formulated. This would be in an
effort to coordinate care and ensure patient safety.
Calling all caregivers to review Med Rec correctness may be beneficial to increasing the
participant number and allowing a clearer picture of physician versus PL data. Ideally, the PL
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would be able to collect all the Med Rec accuracy data via the EHR and the physicians would
not be involved in data collection. However, it is important to consider the time component of
making the correctness telephone calls. The location of the telephone calls should also be taken
into consideration. During the project, the location of the telephone calls was a computer and
phone located in a busy hall, which was less than ideal when explaining the project to patients
and verifying, oftentimes numerous, medications.
Ideally, the physicians would have been educated by the PL regarding data collection
and also would have been present during the team member education component. This may
have increased buy-in to the project. The Med Rec process monitoring was considered time
consuming by team members and is not present in the literature, one could consider not
tracking this. Finally, the team members may have benefited from more individualized Med Rec
accuracy updates. Individualized Med Rec accuracy reports may have increased the
accountability for inaccurate Med Recs.
Strengths and Limitations of the EBP Project
Strengths
Strengths of this project include the use of Kotter’s Model of Change and Stetler’s EBP
Model as a foundation. The use of these frameworks emphasized using existing evidence to
implement and change practice in the clinical setting. The literature, although not specific to the
population and setting, was the foundation for improving the Med Rec process in the pediatric
hematology/oncology outpatient setting. The Stetler EBP Model guided the projects use of
literature to improve a clinical problem. This was in combination with Kotter’s Model of Change
that addressed barriers to change in the real life environment.
The EBP project was focused on a collaborative effort between team members,
caregivers, and patients. This is important given the dynamic, complex medication regimens
many of the pediatric hematology/oncology patients are using. Education included all team
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members present at the unit meeting. The project addressed a topic and clinical problem that
needed attention and improvement.
Upon searching the current literature, common intervention and outcome themes were
found. The intervention and outcomes used during this EBP project were consist with existing
literature. Although the tools used in this project were self-developed by the PL, they were
based on the common terms and components of accurate Med Recs found in the literature. By
using common concepts found in the literature, it allowed the EBP project findings to be
compared to existing literature and guided future modifications and improvement of the project.
Finally, the PL was familiar with the team members, caregivers, patients, and Med Rec
process at the project site. This facilitated a trusting relationship in which improvement was
possible. The PL was able to foresee barriers to improvement and successfully navigate the
implementation of evidence into practice.
Limitations
The specific patient population and setting target of this EBP project limited the
applicable research found by the PL. However, current literature focused on pediatric inpatient
and adult outpatient studies was used to develop an intervention aimed at improving the Med
Rec process and ultimately patient safety.
The data collection, specifically calling the caregivers for correctness verification was
time consuming, and presents a barrier to continuation of the Med Rec accuracy tracking
process. No medication errors were reported during the EBP project timeframe or during the
previous year. Therefore, this was may not have been an appropriate measure of the effect of
inaccurate Med Recs on ADE’s. The EBP project took place in a specific setting, serving a
specific population, this may limit the applicability of the project findings to other clinical settings.
Implications for the Future
The EBP project can impact Med Rec accuracy in the outpatient setting, specifically the
pediatric outpatient setting, in numerous ways. Areas that may be affected by the project
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findings include practice, theory, research, and education. Overall, the project adds to the body
of evidence focused on Med Rec process accuracy and patient safety.
Practice
The implementation of the standardized, collaborative Med Rec process during the EBP
project did result in a significant increase in the matched physician reported accurate Med Recs.
And although not significant, there was an increase in the total physician reported accurate Med
Recs. This indicates that continuation of the patient/caregiver and team member component of
the intervention may be helpful in further improvement of the Med Rec process. In order to
continue tracking of the Med Rec process, specifically the accuracy, tracking measures must be
re-examined and a less time consuming option may be appropriate. It must be determined if
particular parts of the intervention, such as the caregiver reminder to bring their child’s
medications, should continue. Also, continued tracking of the Med Rec process compliance may
not be necessary. The physicians may need to be included in the education and inaccuracy
data updates, as they were not recording numerous incompleteness errors that the PL found.
All team members and caregivers/patients are critical to the success of an accurate Med
Rec process. Without everyone invested in the process improvement, future implemented
measures may meet the same resistance. The MA and nurse are the bridge between the patient
and provider. They are responsible for educating the caregivers/patients regarding their
medications and interacting with the caregiver/patient to produce the most accurate Med Rec.
The pediatric hematology/oncology outpatient clinic may benefit from further discussion
and refinement of the evidence-based intervention. Also, discussions with the IT department
may be beneficial in setting up a process in which the EHR would stop forward movement, a
hard stop, in the Med Rec process unless each medication had a name, dose, frequency, and
route of administration documented. This would eliminate the incompleteness factor of the
inaccurate Med Recs.
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Theory
There is a large amount of literature detailing the role of Med Rec in improving patient
safety. However, there is also discussion in the literature surrounding the difficulties with
implementing an accurate Med Rec process. A barrier discussed in detail in the literature is the
different processes that exist in various settings and with various populations. Using theoretical
and EBP frameworks when implementing evidence into practice in the future will ensure
development and forward movement of refining the Med Rec process. Using the Kotter’s Model
of Change and Stetler’s EBP Model as frameworks for this EBP project facilitated the use of the
best evidence into clinical practice. Future use of the Stetler EBP Model to implement and
improve Med Rec processes is recommended.
Research
In the future, the EBP project could be modified and replicated in the same setting to
strive for further improvement of Med Rec accuracy. The project could also be replicated to
determine if a significant increase in Med Rec accuracy can be achieved in a similar or different
outpatient setting. Implementing similar interventions and outcomes would be helpful in
comparing future findings. There is a lack of literature focused on the Med Rec process in the
pediatric outpatient setting, more research focusing on this specific patient population and
setting would fill this gap.
Education
The education provided to team members during the intervention, regarding the
completeness, correctness, and accuracy of the Med Rec process could be provided to all
healthcare providers and team members regardless of the setting. Moving forward improving
patient safety will continue to be a much discussed topic. Med Rec should be promoted as a
means to improve patient safety. Whether it be in the educational or clinical setting, increasing
knowledge of the importance of an accurate Med Rec process must be a focus. The EHR and
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complexity of medical care today has increased the need for patient and provider collaboration,
in an effort to improve medication safety.
Conclusion
The standardized and collaborative Med Rec process increased the number of physician
reported accurate Med Recs. The physicians reported mostly incorrectness errors, while the PL
reported mostly incompleteness errors. The most commonly assigned Med Rec inaccuracy
severity was class 1 (minor). There were no voluntary reported medication errors during the
duration of the EBP project. In general, the project was well received and shed light on a
process that can lead to improved patient safety. The complexity of oncology care, coupled with
the complexity of pediatric medication administration, places pediatric oncology patients at a
significant risk for medication discrepancies and subsequent adverse drug events (Walsh et al.,
2009). Furthermore, a standardized, collaborative Med Rec process can be used to improve
patient safety in this vulnerable population.
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Appendix A
Pre-Intervention Medication Reconciliation Process Team Member Survey
Pediatric Hematology/Oncology Outpatient Clinic
Medication Reconciliation (Med Rec) Process Team Member Survey Pre-Intervention
Instructions:
Please complete the following items by filling in the blank or marking the item that best
describes you.
Date:

Last three digits of employee number:

Age:

Gender:

Ethnicity:

Female

Male

African American

Asian-Pacific Islander

Caucasian

Hispanic

Native American

Other _________

Highest Level of Education:

Less than high school

Some college

2 year college degree (Associates)

4 year college degree (Bachelors)
Doctoral Degree
Current Employment Status:
Current Position:

Physician

High school/ GED
Master’s Degree

Professional Degree (MD, JD)
Full-time
Nurse

Part-time
Medical Assistant

PRN
Unit Assistant

How long have you worked in this outpatient clinic?
What aspects of the current Med Rec process do you feel are working well?

What aspects of the current Med Rec process do you feel are NOT working well?

Please provide ideas for future improvement of the Med Rec process.
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Appendix B

Post-Intervention Medication Reconciliation Process Team Member Survey
Pediatric Hematology/Oncology Outpatient Clinic
Medication Reconciliation (Med Rec) Process Team Member Survey Post-Intervention
Instructions:
Please complete the following items by filling in the blank or marking the item that best describes you.
Thank you!

Date:

Last three digits of employee number:

Age:

Gender:

Ethnicity:

Female

Male

African American

Asian-Pacific Islander

Caucasian

Hispanic

Native American

Other _________

Highest Level of Education:

Less than high school

Some college

2 year college degree (Associates)

4 year college degree (Bachelors)
Doctoral Degree
Current Employment Status:
Current Position:

Physician

High school/ GED
Master’s Degree

Professional Degree (MD, JD)
Full-time
Nurse

Part-time
Medical Assistant

PRN
Unit Assistant

How long have you worked in this outpatient clinic?
Should the patients/parents continue to be reminded to bring their medications to their next visit?
Yes

No

If not, what is the reason?
If so, do you have any suggestions to improve the reminder?
Should the patient/parent education regarding Med Rec continue?

Yes

No

If not, what is the reason?
If so, do you have any suggestions to improve the education?
Should tracking of the Med Rec process and discrepancies continue?
If not, what is the reason?
If so, do you have any suggestions to improve the monitoring?

Yes

No
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Appendix C

Physician Medication Reconciliation Tracking Form
Patient Initials: _______

Patient DOB: ________
Patient Code Number: __________

Physician Medication Reconciliation Tracking Form
Medication List Information
Yes

No
(if no continue to table below)

Medication list accurate
(Accurate= complete and correct Med Rec)
What makes the Med Rec inaccurate?
(Please provide more information in tables
below.)
A. Incompleteness
(Complete= name, dose, frequency, and route of all
meds documented)
B. Incorrectness
(Correct= no discrepancies between the med list in
EHR and the meds the patient is taking at home)

Medication Discrepancy Data
A. Completeness
Place check next to what med
element is missing.

Name of med(s) missing this information?

Name
Dose
Frequency
Route
B. Correctness
Place check next to what
element is incorrect.
Addition
(med on Med Rec that patient is not taking)
Omission
(med not on Med Rec that patient is taking)
Duplication
(med listed twice)
Incorrect name
(med with incorrect name)
Incorrect dose
(med with incorrect dose)
Incorrect frequency
(med with incorrect frequency)
Incorrect route
(med with incorrect route)

Name of med(s) with the
incorrect information?
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Severity of Discrepancies
Place a check next to the severity of the Med Rec
discrepancy.
Class 1
(potentially minor)
Class 2
(potentially moderate)
Class 3
(potentially severe)
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Appendix D

Project Leader Medication Reconciliation Tracking Form
Project Leader Medication Reconciliation Tracking Form
Patient Code Number: ______
Patient Demographic Data
Age (years)
Gender

Female

Male

Diagnosis
Number of medications the patient is taking
(includes OTC, herbal supplements, vitamins, and
prescriptions)
Was the Med Rec correctness verified via telephone?

Yes

No

Who verified Med Rec correctness via telephone?

Medication List Information
Yes

No
(if no continue to table below)

Medication list accurate
(Accurate= complete and correct Med Rec)

What makes the Med Rec inaccurate?
A. Incompleteness
(Complete= name, dose, frequency, and route of all medications
documented)

B. Incorrectness
(Correct= no discrepancies between the medication list in EHR and
the medications the patient is taking at home)

Medication Discrepancy Data
A. Completeness
Place check next to what med
element is missing.

Name of med(s) missing this information?

Name
Dose
Frequency
Route
B. Correctness
Place check next to what
element is incorrect.
Addition
(med on Med Rec that patient is not taking)
Omission
(med not on Med Rec that patient is taking)
Duplication
(med listed twice)
Incorrect name
(med with incorrect name)

Name of med(s) with this incorrect
information?

MEDICATION RECONCILIATION

103

Incorrect dose
(med with incorrect dose)
Incorrect frequency
(med with incorrect frequency)
Incorrect route
(med with incorrect route)

Severity of Discrepancies
Place a check next to the severity of the Med Rec
discrepancy.
Class 1 (potentially minor)
Class 2 (potentially moderate)
Class 3 (potentially severe)
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Appendix E

Educational Patient Handout

Medication Reconciliation
Medication reconciliation ensures the most up-to-date list of your medications is
available.
This up-to-date list benefits both you and the healthcare team.
Medication reconciliation promotes medication safety.
Medication reconciliation is the responsibility of the patient and the healthcare
team.
Successful medication reconciliation is a collaborative effort.
Medications include:






prescription medications
over-the-counter medications
vitamins
nutritional supplements
complementary medications

Your role in medication reconciliation:



Bring your child’s medications to every visit.
Question you should be able to answer include:
o What medications does your child take, including the name, dose, frequency,
and route?
o Why are they taking them?
o How do they take them?
o When was the last time they took each medication?
o Are they having any problems with their current medications?

Together, with you, we want to improve your child’s medication safety.
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Appendix F
Educational Power Point ®
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Appendix G

Medication Reconciliation Team Member Information Sheet

MEDICATION RECONCILIATION
3 steps:
Verification
Clarification
Reconciliation
Complete
Name, dose, frequency, and route of all meds are documented
Correct
No discrepancies between the med list in the EHR and
the meds the patient is taking at home exist
Accurate
Complete and Correct Med Rec
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Appendix H
Master Coding Form
Master Coding Form

Code
Number
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21

Patient Name

Medical Record Number
(MRN)

DOB
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Appendix I

Medication Reconciliation Process Data Collection Form

Patient Label

Patient Code Number: __________
Medication Reconciliation Process Data Collection Form
Instructions: Please complete the following items for each patient and place the completed form
in the locked box. Thank you.
Task

Yes

Was the caregiver reminded to
bring the patient’s medications
to the next visit?
Did the patient/caregiver bring
their medications to the
appointment?
Was the patient/caregiver given
the brochure and educated
regarding medication
reconciliation, during their visit?
By Who (role)?

MA

Were all three steps of the
medication reconciliation
process completed?
By Who (role)?

Verification

(Verification= generating a list of
the patient’s current medications)
(Clarification= medications are
checked for appropriateness)
(Reconciliation= medication list is
reviewed and any changes are
documented)

Clarification

Nurse
Both
MA
Nurse
Both
MA
Nurse
Both
Reconciliation

Physician

No
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Ethics Training Completion Certificate

